var title_f17_63_18416="Fibroid pseudocapsule";
var content_f17_63_18416=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F66817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F66817&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hysteroscopic myomectomy: leiomyoma pseudocapsule",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 346px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hysteroscopic shelling out of the pseudocapsule surrounding a myoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Linda D Bradley, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18416=[""].join("\n");
var outline_f17_63_18416=null;
var title_f17_63_18417="Erythema annulare centrifugum - light skin";
var content_f17_63_18417=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F80998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F80998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superficial erythema annulare centrifugum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Annular erythematous plaques with \"trailing scale\" are classic features of superficial erythema annulare centrifugum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18417=[""].join("\n");
var outline_f17_63_18417=null;
var title_f17_63_18418="Contents: Primary care gastroenterology";
var content_f17_63_18418=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care gastroenterology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care gastroenterology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Acid peptic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/22/30055\">",
"           Acute and chronic gastritis due to Helicobacter pylori",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/4/27720\">",
"           Approach to the patient with dyspepsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/40/44679\">",
"           Association between Helicobacter pylori infection and duodenal ulcer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/16/43271\">",
"           Bacteriology and epidemiology of Helicobacter pylori infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/30/31205\">",
"           Classification and diagnosis of gastritis and gastropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/18/13609\">",
"           Clinical manifestations of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/21/24919\">",
"           Diagnosis of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/42/19113\">",
"           Epidemiology and etiology of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/28/35272\">",
"           Functional dyspepsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/59/37817\">",
"           Indications and diagnostic tests for Helicobacter pylori infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/10/12455\">",
"           Management of duodenal ulcers in patients infected with Helicobacter pylori",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/31/38393\">",
"           NSAIDs (including aspirin): Primary prevention of gastroduodenal toxicity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/21/40282\">",
"           Overview of the complications of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/18/42281\">",
"           Overview of the natural history and treatment of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/15/24826\">",
"           Overview of the treatment of bleeding peptic ulcers",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/44/4809\">",
"           Pathophysiology of and immune response to Helicobacter pylori infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/47/13049\">",
"           Pharmacology of antiulcer medications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/61/16345\">",
"           Refractory or recurrent peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/57/33688\">",
"           Role of surgery in the management of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/5/40025\">",
"           Surgical management of complications of peptic ulcer disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/32/23049\">",
"           Treatment regimens for Helicobacter pylori",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/0/19466\">",
"           Unusual causes of peptic ulcer disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Biliary and pancreatic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/37/6742\">",
"           Acalculous cholecystitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/13/24790\">",
"           Acute cholangitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/8/10374\">",
"           Approach to the patient with incidental gallstones",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/57/7065\">",
"           Classification and causes of jaundice or asymptomatic hyperbilirubinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/5/20569\">",
"           Clinical manifestations and diagnosis of acute pancreatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/13/30935\">",
"           Clinical manifestations and diagnosis of chronic pancreatitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/40/41610\">",
"           Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/50/42790\">",
"           Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/16/6408\">",
"           Dissolution therapy for the treatment of gallstones",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/24/4489\">",
"           Epidemiology of and risk factors for gallstones",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/41/39575\">",
"           Etiology and pathogenesis of chronic pancreatitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/61/14297\">",
"           Etiology of acute pancreatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/19/34105\">",
"           Overview of the treatment of primary biliary cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/33/29208\">",
"           Pathogenesis, clinical features, and diagnosis of acute cholecystitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/15/14582\">",
"           Patient selection for the nonsurgical treatment of gallstone disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/29/44504\">",
"           Predicting the severity of acute pancreatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/19/23863\">",
"           Pruritus associated with cholestasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/9/15511\">",
"           Treatment of acute cholecystitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/40/31369\">",
"           Treatment of chronic pancreatitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/8/41097\">",
"           Treatment of primary sclerosing cholangitis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Esophageal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/56/15240\">",
"           Chest pain of esophageal origin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/26/14759\">",
"           Clinical manifestations and diagnosis of achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/41/22168\">",
"           Clinical manifestations and diagnosis of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/51/19253\">",
"           Complications of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/8/1161\">",
"           Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/17/12569\">",
"           Evaluation of dysphagia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/19/21814\">",
"           Globus sensation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/19/43317\">",
"           Mallory-Weiss syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/61/35802\">",
"           Management of Barrett's esophagus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/53/42840\">",
"           Medical management of gastroesophageal reflux disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/13/37078\">",
"           Medication-induced esophagitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/39/18039\">",
"           Overview of the treatment of achalasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/38/13928\">",
"           Pathophysiology of reflux esophagitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/57/42905\">",
"           Surgical management of gastroesophageal reflux in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/52/29512\">",
"           Zenker's diverticulum",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal bleeding",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/55/28538\">",
"           Approach to acute upper gastrointestinal bleeding in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/63/8184\">",
"           Approach to minimal bright red bleeding per rectum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/7/30841\">",
"           Approach to resuscitation and diagnosis of acute lower gastrointestinal bleeding in the adult patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/49/38679\">",
"           Colonic diverticular bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/6/7272\">",
"           Etiology of lower gastrointestinal bleeding in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/4/11336\">",
"           Evaluation of occult gastrointestinal bleeding",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/56/1928\">",
"           General principles of the management of variceal hemorrhage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/23/12664\">",
"           Major causes of upper gastrointestinal bleeding in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/60/21446\">",
"           Prediction of variceal hemorrhage in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/49/27418\">",
"           Primary and pre-primary prophylaxis against variceal hemorrhage in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/56/41865\">",
"           Uncommon causes of upper gastrointestinal bleeding in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/63/8184\">",
"           Approach to minimal bright red bleeding per rectum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/62/32746\">",
"           Approach to the patient with colonic polyps",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/36/2634\">",
"           Association between Helicobacter pylori infection and gastrointestinal malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/36/11850\">",
"           Clinical features, diagnosis, and staging of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/43/40633\">",
"           Clinical manifestations and diagnosis of cholangiocarcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/33/17946\">",
"           Clinical manifestations, diagnosis, and staging of colorectal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/40/41610\">",
"           Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/7/25722\">",
"           Colorectal cancer surveillance in inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/31/18938\">",
"           Epidemiology, clinical features, and types of small bowel neoplasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/54/43881\">",
"           Epidemiology, pathogenesis, and classification of cholangiocarcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/14/16618\">",
"           Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/5/29783\">",
"           Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management of patients and families",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/3/43063\">",
"           Overview of treatment approaches for hepatocellular carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/12/8391\">",
"           Pathogenesis of Barrett's esophagus and its malignant transformation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/9/3224\">",
"           Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/52/6983\">",
"           Screening and prevention of gastric cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/10/37034\">",
"           Screening for colorectal cancer: Strategies in patients at average risk",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/7/5242\">",
"           Acute appendicitis in adults: Management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/21/44377\">",
"           Acute mesenteric ischemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/24/34181\">",
"           Anal fissure: Clinical manifestations, diagnosis, prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/48/15110\">",
"           Approach to the patient with anal pruritus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/27/33206\">",
"           Chronic mesenteric ischemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/10/14504\">",
"           Clinical manifestations and diagnosis of Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/6/34919\">",
"           Clinical manifestations and diagnosis of colonic diverticular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/59/22455\">",
"           Clinical manifestations and diagnosis of irritable bowel syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/0/20490\">",
"           Clinical manifestations, diagnosis and prognosis of Crohn's disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/7/11386\">",
"           Clinical manifestations, diagnosis, and prognosis of ulcerative colitis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/20/42313\">",
"           Colonic ischemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/17/7450\">",
"           Definition, epidemiology, and risk factors in inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/63/36854\">",
"           Epidemiology and pathophysiology of colonic diverticular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/14/25834\">",
"           Fertility, pregnancy, and nursing in inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/22/7527\">",
"           Hiatus hernia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/51/6968\">",
"           Management and prognosis of the Zollinger-Ellison syndrome (gastrinoma)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/36/22090\">",
"           Management of mild to moderate ulcerative colitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/10/2218\">",
"           Management of patients with a colostomy or ileostomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/15/3319\">",
"           Management of severe ulcerative colitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/49/17177\">",
"           Nonselective NSAIDs: Overview of adverse effects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/14/5348\">",
"           Overview of hemorrhoids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/54/19305\">",
"           Overview of the medical management of mild to moderate Crohn's disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/11/6329\">",
"           Overview of the medical management of severe or refractory Crohn's disease in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/40/26246\">",
"           Perianal abscess: Clinical manifestations, diagnosis, treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/22/29034\">",
"           Pulmonary complications of inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/53/26453\">",
"           Sigmoid volvulus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/24/41350\">",
"           Skin and eye manifestations of inflammatory bowel disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/46/14058\">",
"           Small bowel obstruction: Causes and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/38/8807\">",
"           Small bowel obstruction: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/50/4906\">",
"           Surgical management of ulcerative colitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/8/13450\">",
"           Treatment of acute diverticulitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/61/6105\">",
"           Treatment of hemorrhoids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/14/40169\">",
"           Treatment of irritable bowel syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/17/32025\">",
"           Approach to the adult with acute diarrhea in developed countries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/48/26376\">",
"           Clinical presentation and diagnosis of rotavirus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/39/29305\">",
"           Clostridium difficile in adults: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/18/36137\">",
"           Clostridium difficile in adults: Epidemiology, microbiology, and pathophysiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/29/20954\">",
"           Clostridium difficile in adults: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/29/29145\">",
"           Travelers' diarrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/26/39334\">",
"           Treatment and prevention of Shigella infection in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/1/4121\">",
"           Treatment and prophylaxis of spontaneous bacterial peritonitis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal symptoms",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/1/15384\">",
"           Anal fissure: Medical and surgical management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/63/8184\">",
"           Approach to minimal bright red bleeding per rectum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/55/43897\">",
"           Approach to the adult with chronic diarrhea in developed countries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/47/16120\">",
"           Approach to the adult with nausea and vomiting",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/4/27720\">",
"           Approach to the patient with dyspepsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/48/19208\">",
"           Characteristics of antiemetic drugs",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/14/35048\">",
"           Constipation in the older adult",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/36/19018\">",
"           Diagnostic approach to abdominal pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/30/16874\">",
"           Differential diagnosis of abdominal pain in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/46/26345\">",
"           Epidemiology and causes of acute diarrhea in developed countries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/22/13673\">",
"           Etiology and evaluation of chronic constipation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/59/22458\">",
"           Fecal incontinence in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/28/35272\">",
"           Functional dyspepsia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/24/40323\">",
"           History and physical examination in adults with abdominal pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/18/24872\">",
"           Intestinal gas and bloating",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/57/30616\">",
"           Management of chronic constipation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/36/22087\">",
"           Overview of hiccups",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/4/28744\">",
"           Alcoholic hepatitis: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/43/698\">",
"           Alcoholic hepatitis: Natural history and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/18/34090\">",
"           Approach to the patient with abnormal liver biochemical and function tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/35/12858\">",
"           Assessing surgical risk in patients with liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/28/36294\">",
"           Clinical aspects of serum bilirubin determination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/42/21162\">",
"           Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/22/34153\">",
"           Clinical manifestations and diagnosis of hepatic encephalopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/63/22521\">",
"           Clinical manifestations and diagnosis of primary sclerosing cholangitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/41/23194\">",
"           Diagnostic approach to the patient with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/50/42790\">",
"           Diagnostic approach to the patient with jaundice or asymptomatic hyperbilirubinemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/57/19353\">",
"           Enzymatic measures of cholestasis (eg, alkaline phosphatase, 5���������-nucleotidase, gamma-glutamyl transpeptidase)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/43/14010\">",
"           Evaluation of adults with ascites",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/23/42359\">",
"           Gilbert's syndrome and unconjugated hyperbilirubinemia due to bilirubin overproduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/15/4346\">",
"           Hepatic encephalopathy in adults: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/10/14506\">",
"           Hepatic encephalopathy: Pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/2/25642\">",
"           Hepatotoxicity due to herbal medications and dietary supplements",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/44/19145\">",
"           Initial therapy of ascites in patients with cirrhosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/63/21494\">",
"           Liver biochemical tests that detect injury to hepatocytes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/20/5446\">",
"           Patterns of plasma aspartate and alanine aminotransferase levels with and without liver disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/15/12535\">",
"           Screening for hereditary hemochromatosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/29/24022\">",
"           Tests of the liver's biosynthetic capacity (eg, albumin, coagulation factors, prothrombin time)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/48/14088\">",
"           Tests used in the diagnosis of Wilson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/32/18952\">",
"           Treatment of hereditary hemochromatosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Hepatitis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/30/15847\">",
"           Approach to patients with chronic hepatitis C virus infection and normal serum aminotransferases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/13/32980\">",
"           Atypical manifestations of hepatitis A virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/35/21045\">",
"           Characteristics of the hepatitis B virus and pathogenesis of infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/5/29780\">",
"           Characteristics of the hepatitis C virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/50/31530\">",
"           Clinical manifestations and natural history of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/26/30122\">",
"           Clinical manifestations and natural history of hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/7/2169\">",
"           Epidemiology and transmission of hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/31/4602\">",
"           Epidemiology, transmission, and prevention of hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/38/1641\">",
"           Hepatitis A virus vaccination and postexposure prophylaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/60/31690\">",
"           Hepatitis B virus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/55/23416\">",
"           Management of healthcare workers exposed to hepatitis B virus or hepatitis C virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/59/35768\">",
"           Mechanism of action and efficacy of standard interferon alfa for the treatment of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/26/7591\">",
"           Overview of hepatitis A virus infection in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/45/43735\">",
"           Overview of the management of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/59/38841\">",
"           Patient selection for antiviral therapy for chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/55/41849\">",
"           Screening for and diagnosis of chronic hepatitis C virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/60/14281\">",
"           Standard and pegylated interferon for chronic hepatitis B virus infection",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-C115FBEEA7-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f17_63_18418=[""].join("\n");
var outline_f17_63_18418=null;
var title_f17_63_18419="Toxic epidermal necrolysis I";
var content_f17_63_18419=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Toxic epidermal necrolysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Usually caused by drugs, toxic epidermal necrolysis demonstrates widespread erythema and confluent vesiculation, leading to sloughing of the skin. Affected patients are at risk for hypernatremic dehydration and sepsis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lee T Nesbitt, Jr. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore, 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18419=[""].join("\n");
var outline_f17_63_18419=null;
var title_f17_63_18420="Thoracic dermatomes 2";
var content_f17_63_18420=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64754&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64754&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Thoracic dermatomes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 447px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18420=[""].join("\n");
var outline_f17_63_18420=null;
var title_f17_63_18421="Immunologic synapse";
var content_f17_63_18421=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F69555&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F69555&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Immunologic synapse",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 402px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Antigen presenting cells are illustrated as presenting a peptide bound to HLA forming an \"immunologic synapse\" with the T cell immunoreceptor. Notice the presence of secondary messenger systems such as the CD-28 and B7 molecules, which also come into apposition to allow a T cell response. Local adhesion molecules are thought to help stabilize the synapse.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18421=[""].join("\n");
var outline_f17_63_18421=null;
var title_f17_63_18422="Algorithm for acute weight loss in children and adolescents";
var content_f17_63_18422=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F87725%7EEM%2F87726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F87725%7EEM%2F87726&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 647px\">",
"   <div class=\"ttl\">",
"    Diagnostic algorithm for acute weight loss in children and adolescents*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 627px; height: 474px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Weight loss occuring over approximately one week.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Once fluid and physical exam status normalized, patients with dehydration should be evaluated as for patients who were NOT initially ill-appearing.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 644px\">",
"   <div class=\"ttl\">",
"    Diagnostic algorithm for chronic weight loss in children and adolescents*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 624px; height: 809px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Chronic weight loss refers to decreased body weight over more than one to two weeks.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      Fever may",
"      <strong>",
"       not",
"      </strong>",
"      always be present in patients with weight loss caused by malignancy.",
"      <br>",
"       &Delta; Several chronic infections may cause weight loss in association with prolonged fever and nonspecific and variable clinical findings such as lymphadenopathy, hepatitis, and myalgias including brucellosis, leptospirosis, tularemia, and Epstein-Barr virus. For more information&nbsp;refer to UpToDate topics on fever of unknown origin.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18422=[""].join("\n");
var outline_f17_63_18422=null;
var title_f17_63_18423="Echinocytes";
var content_f17_63_18423=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F62090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F62090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Echinocytes (burr cells)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 233px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Peripheral blood smear showing numerous echinocytes, also known as burr cells. Echinocytes are often confused with acanthocytes. However, the projections of the red cell membrane in echinocytes are smaller and much more regular in shape and distribution than in acanthocytes. It may be difficult on stained slides to distinguish echinocytes from spur cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal peripheral blood smear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of a normal peripheral blood smear. Several platelets (black arrows) and a normal lymphocyte (blue arrow) can also be seen. The red cells are of relatively uniform size and shape. The diameter of the normal red cell should approximate that of the nucleus of the small lymphocyte; central pallor (red arrow) should equal one-third of its diameter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carola von Kapff, SH (ASCP).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18423=[""].join("\n");
var outline_f17_63_18423=null;
var title_f17_63_18424="Phyllodes tumors of the breast";
var content_f17_63_18424=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Phyllodes tumors of the breast",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Ana M Grau, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18424/contributors\">",
"     A Bapsi Chakravarthy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Rashmi Chugh, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Lori J Pierce, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Anees B Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18424/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/63/18424/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phyllodes tumors are uncommon fibroepithelial breast tumors that are capable of a diverse range of biologic behavior. In their least aggressive form, they behave similarly to benign fibroadenomas, although with a propensity to recur locally following excision without wide margins. At the other end of the spectrum are tumors that metastasize distantly, sometimes degenerating histologically into sarcomatous lesions that lack an epithelial component [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The terminology of phyllodes tumors has evolved. All such tumors were originally called \"cystosarcoma phyllodes\" by Johannes Muller in 1838 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1\">",
"     1",
"    </a>",
"    ]. However, they only occasionally have cystic components, and they are not true sarcomas by either cellular origin or biologic behavior. The term \"phyllodes\", which means leaf-like, describes the typical papillary projections that are seen on pathologic examination. Since the original description, over 60 synonyms have been applied to this entity until the adoption of the term phyllodes tumors by the World Health Organization [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phyllodes tumors account for fewer than 0.5 percent of all breast malignancies [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Given their rarity, epidemiologic data are scant. In a study from Los Angeles county over a 17 year period, the average annual incidence rate was 2.1 per million women, and there was a higher incidence in Latina whites, as compared to non-Latina whites, Asians, and African American women [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The vast majority occur in women, in whom the median age at presentation is 42 to 45 (range 10 to 82 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/3,6-8\">",
"     3,6-8",
"    </a>",
"    ]. Data indicate that the tumor grade increases with mean age at diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/9\">",
"     9",
"    </a>",
"    ]. Some case reports describe these tumors in men, usually in association with gynecomastia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No etiologic or predisposing factors have been associated with phyllodes tumors, with the exception of Li-Fraumeni syndrome, a rare autosomal dominant condition that is characterized by the development of multiple tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=see_link&amp;anchor=H18#H18\">",
"     \"Characteristics of hereditary breast and ovarian cancer syndromes\", section on 'Li-Fraumeni syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12391?source=see_link\">",
"     \"Li-Fraumeni syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some believe that phyllodes tumors arise from benign epithelial fibroadenomas due to their close histologic resemblance and molecular similarities [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1,3,11\">",
"     1,3,11",
"    </a>",
"    ]. However, this remains an ongoing debate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11081?source=see_link\">",
"     \"Overview of benign breast disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phyllodes tumors are generally first identified as a breast mass or an abnormal mammographic finding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;On examination, most patients have a smooth, multinodular, well-defined, firm mass that is mobile and painless [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. Tumor size is variable, ranging from 1 to 41 cm (average 4 to 7 cm) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4,8\">",
"     4,8",
"    </a>",
"    ]. Shiny, stretched, and attenuated skin may be seen overlying a large tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1\">",
"     1",
"    </a>",
"    ]. Nipple retraction, ulceration, chest wall fixation, and bilateral disease are rare but described [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1,12\">",
"     1,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tumors may be slow or rapidly growing, or they may exhibit a biphasic growth pattern. As they grow, phyllodes tumors can distort the breast or cause superficial ulceration through pressure necrosis. The mass may be visible on inspection, especially if it expands quickly.",
"   </p>",
"   <p>",
"    Although palpable axillary lymphadenopathy can be identified in up to 20 percent of patients, metastatic involvement of lymph nodes is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4,7\">",
"     4,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical appearance of a phyllodes tumor on mammography is a smooth, polylobulated mass resembling a fibroadenoma [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1\">",
"     1",
"    </a>",
"    ]. Approximately 20 percent of phyllodes tumors present as a nonpalpable mass identified on screening mammography [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39482?source=see_link\">",
"     \"Breast imaging: Mammography and ultrasonography\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/36/24138?source=see_link\">",
"     \"Diagnostic evaluation of women with suspected breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Suspicion for a phyllodes tumor rather than a fibroadenoma is based on large tumor size at presentation or rapid growth [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1\">",
"     1",
"    </a>",
"    ]. Patients with a suspicious lesion on mammography should have an ultrasound examination. Phyllodes lesions are primarily solid, hypoechoic and well circumscribed on ultrasonography. Although not always present, cystic areas within the mass may increase the level of suspicion for phyllodes tumors&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of magnetic resonance imaging (MRI) in the diagnosis and management of phyllodes tumors is not clear [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/15\">",
"     15",
"    </a>",
"    ]. A retrospective study of 30 patients with biopsy confirmed phyllodes tumors showed that malignant phyllodes tumors are seen as well-circumscribed tumors with irregular walls, high signal intensity on T1-weighted images and low signal intensity on T2-weighted images [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/16\">",
"     16",
"    </a>",
"    ]. Cystic change may be seen as well. Interestingly, a rapid enhancement pattern is seen more commonly with benign rather than malignant phyllodes tumors, which is the opposite of the pattern seen with adenocarcinomas of the breast [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When the diagnosis of a phyllodes tumor has been made on core biopsy, breast MRI may prove helpful in determining the extent of disease and facilitating pre-operative planning [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/17\">",
"     17",
"    </a>",
"    ]. However, the use of breast MRI in surgical planning for phyllodes tumors is controversial as there are very little data on its role in this setting as they are so rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fine needle aspiration biopsy has been associated with high false negative results and low overall accuracy for the diagnosis of phyllodes tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/18\">",
"     18",
"    </a>",
"    ]. However, special attention to three major cytological features (fibromyxoid stromal fragments with spindle nuclei, fibroblastic pavements, and spindle cells of fibroblastic nature) can improve the diagnosis of phyllodes tumor on FNA [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Core needle biopsy is the preferred method for making a diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/20\">",
"     20",
"    </a>",
"    ]. There are some features that are useful in distinguishing phyllodes tumors and fibroadenomas on core biopsy. These include increased cellularity, mitosis, stromal overgrowth, and fragmentation (stroma with epithelium at one or both ends of the fragment) of the biopsy specimen.",
"   </p>",
"   <p>",
"    A core needle biopsy of a phyllodes tumor can result in a 25 to 30 percent false negative rate [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. For this reason, if a solid mass has a benign biopsy but subsequently exhibits rapid growth or becomes symptomatic, excisional biopsy should be performed. Additionally, if a core biopsy is indeterminate, then an excisional biopsy will be necessary to make the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24504?source=see_link\">",
"     \"Breast biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Grossly, phyllodes tumors are round to oval multinodular masses with a grayish white appearance that resemble the head of a cauliflower; they may be indistinguishable from fibroadenomas (",
"    <a class=\"graphic graphic_picture graphicRef51479 \" href=\"UTD.htm?14/12/14532\">",
"     picture 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1\">",
"     1",
"    </a>",
"    ]. Phyllodes tumors grow radially creating a pseudocapsule through which tongues of stroma may protrude and grow into adjacent breast tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/24\">",
"     24",
"    </a>",
"    ]. Necrosis and hemorrhage can occur in larger tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Microscopically, the range of appearances covers the spectrum from resembling a benign fibroadenoma to a high-grade sarcoma. The characteristic leaf-like architecture consists of elongated cleft-like spaces that contain papillary projections of epithelial-lined stroma with varying degrees of hyperplasia and atypia (",
"    <a class=\"graphic graphic_figure graphicRef78624 \" href=\"UTD.htm?39/25/40339\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/3\">",
"     3",
"    </a>",
"    ].The stromal elements are a key component in the differentiation of phyllodes tumors from fibroadenomas and in distinguishing a benign from a malignant phyllodes tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histologically, phyllodes tumors are classified as benign, borderline or malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1,4,25\">",
"     1,4,25",
"    </a>",
"    ]. The most commonly accepted criteria used for classification of benign versus malignant tumors are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4,6,7,26,27\">",
"     4,6,7,26,27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The degree of stromal cellular atypia",
"     </li>",
"     <li>",
"      Mitotic activity",
"     </li>",
"     <li>",
"      Infiltrative as compared to circumscribed tumor margins",
"     </li>",
"     <li>",
"      Presence or absence of stromal overgrowth (ie, presence of pure stroma devoid of epithelium)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In most large series, more than 50 percent of phyllodes tumors are classified as benign [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1,26\">",
"     1,26",
"    </a>",
"    ]. Approximately 25 percent of phyllodes tumors are malignant, although this figure varies significantly depending on the series [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1,2,28\">",
"     1,2,28",
"    </a>",
"    ]. The classification criteria are summarized here [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Benign phyllodes tumors are characterized by increased stromal cellularity with mild to moderate cellular atypia, circumscribed tumor margins and low mitotic rate (less than 4 mitoses per 10 high power fields) and lack of stromal overgrowth.",
"     </li>",
"     <li>",
"      Borderline tumors have a greater degree of stromal cellularity and atypia, a mitotic rate from 4 to 9 mitosis per 10 high power fields, microscopic infiltrative borders, and lack of stromal overgrowth.",
"     </li>",
"     <li>",
"      Malignant phyllodes tumors are characterized by marked stromal cellularity and atypia, infiltrative margins, high mitotic rate (more than 10 mitosis per 10 high power fields examined), and by the presence of stromal overgrowth [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4,7,26,27\">",
"       4,7,26,27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some authors have suggested that these histologically defined categories may not reliably predict clinical behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. When strict adherence to well-established histologic criteria are used, benign and borderline phyllodes tumors rarely recur following wide excision [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/29\">",
"     29",
"    </a>",
"    ]. In a series of 443 women treated for phyllodes tumor, multivariate analysis was performed on a subset of 146 patients for whom there was no missing data and all variables could be analyzed. Patients with benign tumors had improved local control and disease-free survival compared to patients with borderline and malignant lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stromal overgrowth is consistently associated with aggressive (metastatic) behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/2,31\">",
"     2,31",
"    </a>",
"    ]. Most clinically",
"    <span class=\"nowrap\">",
"     malignant/metastatic",
"    </span>",
"    phyllodes tumors reported have had overgrowth of one or several sarcomatous elements. These include liposarcoma, malignant fibrous histiocytoma, rhabdosarcoma, chondrosarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. Close examination of the stroma is imperative as the sarcomatous component may be present in only a small portion of the phyllodes tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation of tumor markers such as p53, Ki-67, epidermal growth factor receptors, c-kit, platelet-derived growth factor and others in phyllodes tumors has failed to adequately predict outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/24\">",
"     24",
"    </a>",
"    ]. The expression of estrogen and progesterone receptors is common in the epithelial component but uncommon in the stromal component of phyllodes tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the small number of patients with phyllodes tumors, treatment principles are based mainly on retrospective series and case reports. Because of their clinical behavior and prognosis, phyllodes tumors should be treated as primary breast sarcomas rather than infiltrating ductal carcinomas [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Surgical resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon a retrospective review of 164 patients, surgical approach should include a wide local excision with histologic margins negative for malignant cells [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/35\">",
"     35",
"    </a>",
"    ]. Other studies suggest a histologic margin of at least 1 cm, which is much larger than what is required for invasive or in situ breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/2,4,36\">",
"     2,4,36",
"    </a>",
"    ]. Unfortunately, local excision without attention to margins is often performed, particularly since phyllodes tumors are often misdiagnosed as fibroadenomas preoperatively. Recurrence rates are unacceptably high following either local excision or enucleation without negative margins [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/29,37\">",
"     29,37",
"    </a>",
"    ]. Breast conserving therapy is appropriate for nonmalignant as well as malignant lesions as long as adequate margins can be achieved [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/2,4,13\">",
"     2,4,13",
"    </a>",
"    ]. Reexcision is indicated when necessary to ensure acceptable margins [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4,5,13,14,25,29,30,34,36-39\">",
"     4,5,13,14,25,29,30,34,36-39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several reports indicate that wide excision yields local recurrence rates of 8 percent for benign phyllodes tumors and 21 to 36 percent for borderline and malignant tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/29,36\">",
"     29,36",
"    </a>",
"    ]. When appropriate margins are not obtained the recurrence rates are much higher. In a retrospective review of 48 women with high-grade malignant phyllodes tumors, 10 patients were treated with local excision (margins &lt;1 cm), 14 with wide local excision (margins &ge;1 cm) and 24 with mastectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/37\">",
"     37",
"    </a>",
"    ]. Average tumor size was 7.8 cm and median follow up was 9 years. The recurrence rates were 60 percent for those treated with local excision only as compared with 28 percent for those who were treated with wide local excision with appropriate margins. Local recurrence and cancer-specific survival were related to tumor size and excision margins.",
"   </p>",
"   <p>",
"    Even large tumors may be effectively treated with breast conservation without compromising cancer-specific survival [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/13\">",
"     13",
"    </a>",
"    ]. In data from the Surveillance, Epidemiology and End Results (SEER) database on 821 women being treated for malignant phyllodes tumors, mastectomy and wide excision were performed in 52 percent and 48 percent of women respectively. Wide excision was associated with equivalent or improved cause-specific survival relative to mastectomy, regardless of tumor size.",
"   </p>",
"   <p>",
"    Axillary dissection is usually not required since axillary lymph node involvement is only rarely reported, even with malignant tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/5,7,13,38,40\">",
"     5,7,13,38,40",
"    </a>",
"    ]. In the SEER database cited above, only eight of 498 women with known lymph node status had involved nodes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adjuvant radiotherapy (RT) for phyllodes tumors is controversial. Radiotherapy is unnecessary for benign phyllodes tumors that are widely excised. However, some data suggest that adjuvant RT should be considered for patients with histologically malignant phyllodes tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/26-28,40\">",
"     26-28,40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A large retrospective study of patients with malignant phyllodes tumors treated with surgical resection alone revealed suboptimal five-year local control rates (79 percent in 169 patients treated with wide excision and 91 percent in 207 patients treated with mastectomy) [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/41\">",
"       41",
"      </a>",
"      ]. The authors concluded that for patients with malignant phyllodes tumors, particularly over 2 cm in diameter and treated with wide excision alone, adjuvant RT should be strongly considered. One important limitation of this study is the lack of information about margin status.",
"     </li>",
"     <li>",
"      In a study of 443 women treated for phyllodes tumor, RT was associated with a superior local control rate at 10 years, from 59 percent to 86 percent for borderline and malignant phyllodes tumors [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective multi-institutional study of adjuvant RT in 46 patients with borderline malignant or malignant phyllodes tumors treated with breast conserving surgery followed by RT, there were no local recurrences with a median follow up of 56 months [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/36\">",
"       36",
"      </a>",
"      ]. Two patients with malignant phyllodes tumor died of metastatic disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Taken together, these results indicate that adjuvant RT appears to be effective in decreasing recurrences after breast conserving resection for borderline or malignant phyllodes tumors. Most agree that adjuvant RT is appropriate when it is not possible to obtain a wide margin of &ge;1 cm of resection. It is also important to remember that, for some tumors a 1 cm margin may not be possible even with a total mastectomy, due to size or location. In such patients, radiation may be indicated even after a mastectomy.",
"   </p>",
"   <p>",
"    There is less agreement about the role of adjuvant RT when wide margins &ge;1 cm can be obtained. Available data indicates that RT will substantially reduce recurrence for these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/36\">",
"     36",
"    </a>",
"    ]. We suggest RT in this setting but recognize that this is not uniformly recommended by others. Further studies are needed to determine when adjuvant RT should be advised in the treatment of phyllodes tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=see_link\">",
"     \"Role of radiation therapy in breast conservation therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefit of adjuvant chemotherapy is controversial. There have been no randomized studies of adjuvant therapy specifically in phyllodes tumors. An observational study included 28 patients with malignant phyllodes tumors treated over a 10-year period (1993-2003) with either adjuvant",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/49/4887?source=see_link\">",
"     dacarbazine",
"    </a>",
"    or observation alone after surgical resection. Treatment was based upon patient preference [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/42\">",
"     42",
"    </a>",
"    ]. There was no difference in relapse-free survival between the two groups. However, the study was small, retrospective, and uncontrolled, and did not utilize",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/25/38297?source=see_link\">",
"     ifosfamide",
"    </a>",
"    in combination with doxorubicin (which is superior to dacarbazine plus doxorubicin in other soft tissue sarcomas). The likely bias is that patients with more aggressive disease would opt for treatment while those with more favorable disease might choose observation.",
"   </p>",
"   <p>",
"    Based on limited data and experiences in soft tissue sarcoma, adjuvant chemotherapy should be administered only for a minority of patients with large (&gt;5 cm), high-risk or recurrent malignant tumors, and only after a thorough discussion about the risks and benefits of treatment. Patients with benign or borderline phyllodes tumors should not be offered chemotherapy. Guidelines for treating sarcomas rather than adenocarcinomas of the breast should be followed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/11/14521?source=see_link\">",
"     \"Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Hormone therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hormone therapy is not effective for phyllodes tumors despite the presence of positive hormone receptors in the epithelial component of some of these tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/12,43\">",
"     12,43",
"    </a>",
"    ]. The stromal component is the principle neoplastic cell population responsible for the metastatic behavior in these tumors and expresses primarily estrogen receptor beta as opposed to the alpha receptor expressed in adenocarcinomas of the breast [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients with benign and borderline phyllodes tumors are cured with surgery. The survival rate for malignant phyllodes tumors is reported as approximately 60 to 80 percent at 5 years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/2,13,34\">",
"     2,13,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of histology on survival was explored in the SArcoma and PHYllode Retrospective (SAPHYR) Study, a retrospective study of 70 patients with primary breast sarcomas and phyllodes tumors treated from 1966 to 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/34\">",
"     34",
"    </a>",
"    ]. The overall three year survival rate for combined benign and borderline tumors was 100 percent. The overall three year survival rate for malignant phyllodes tumors was 54 percent, similar to that of nonangiosarcoma primary breast sarcomas (60 percent).",
"   </p>",
"   <p>",
"    Similarly, in a retrospective study of 101 patients treated between 1944 and 1998, the overall survival for patients with combined benign and borderline tumors was 91 percent at 5 years. The five year survival rate for malignant phyllodes tumors was 82 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/2\">",
"     2",
"    </a>",
"    ]. Eight patients in this series developed distant metastases (seven of whom had tumors classified as histologically malignant, and one benign); all of these had stromal overgrowth, and six were &ge; 5 cm in size.",
"   </p>",
"   <p>",
"    In another retrospective review of 293 phyllodes tumors, treated between 1954 and 2005, five patients developed distant disease, all of these had infiltrative borders, marked stromal overgrowth, marked stromal cellularity, high mitotic count, and necrosis and were &ge;7 cm in size. [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/8\">",
"     8",
"    </a>",
"    ]. Of note, six of the locally recurrent benign phyllodes tumors recurred as malignant.",
"   </p>",
"   <p>",
"    There are several case reports documenting the ability of benign tumors to undergo malignant transformation, which points to the dilemma that there are no absolute predictive factors for these rare tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/2,8,28,46\">",
"     2,8,28,46",
"    </a>",
"    ]. However, in the majority of cases, when strict adherence to established histological classification criteria are followed and adequate surgical margins are obtained, benign and borderline phyllodes tumors rarely recur [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/24,29\">",
"     24,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     ADVANCED AND RECURRENT DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Local recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;When tumors recur, they typically recur locally within two years of initial excision [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4,12\">",
"     4,12",
"    </a>",
"    ]. Some series have found that time to local recurrence is shorter for patients with malignant phyllodes compared with patients with benign and borderline phyllodes&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Locally recurrent disease is best treated with re-excision with wide margins or mastectomy followed by RT to help avoid the morbidity of yet another recurrence and the need for additional aggressive surgical intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/20\">",
"     20",
"    </a>",
"    ]. For patients with locally unresectable tumors, another option would be palliative radiation alone. In a case of a patient with high-grade tumor recurrence that could not be excised, radiation treatment resulted in local control for 84 months after recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/14\">",
"     14",
"    </a>",
"    ]. There are no prospective randomized trial data regarding the best treatment for recurrent phyllodes tumors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Metastatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metastatic disease has been reported in 13 to 40 percent of patients. [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/1,2,4,18\">",
"     1,2,4,18",
"    </a>",
"    ]. Metastases most frequently involve the lungs. After the development of metastases, mean overall survival is 30 months [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with other soft tissue sarcomas, pulmonary resection is often indicated when feasible. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/40/44680?source=see_link\">",
"     \"Surgical treatment and other localized therapy for metastatic soft tissue sarcoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with unresectable disease, chemotherapy is based upon treatment guidelines for soft tissue sarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/4,48\">",
"     4,48",
"    </a>",
"    ]. The regimen typically consists of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/25/38297?source=see_link\">",
"     ifosfamide",
"    </a>",
"    , or a combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    . Ifosfamide appears to be a particularly active agent, with two of four patients achieving a complete response in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/48\">",
"     48",
"    </a>",
"    ]. Others suggest benefit with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    plus either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/43\">",
"     43",
"    </a>",
"    ] or doxorubicin [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/11/14521?source=see_link\">",
"     \"Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14605481\">",
"    <span class=\"h1\">",
"     SURVEILLANCE AFTER THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the small number of patients with malignant phyllodes tumors of the breast, there are no evidence based recommendations for surveillance after therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. Follow-up guidelines are adapted from those for soft tissue sarcoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/47/38650?source=see_link&amp;anchor=H32#H32\">",
"     \"Local treatment for primary soft tissue sarcoma of the extremities and chest wall\", section on 'Posttreatment cancer surveillance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most recurrences occur in the first two years after treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18424/abstract/36\">",
"     36",
"    </a>",
"    ] and most frequently involve the lungs. Since isolated limited metastatic tumor to the lung is often asymptomatic and amenable to resection, we follow patients closely for at least two years:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History and physical examination and chest x-ray every six months for two years, then annually. If suspicious findings are found on breast examination, mammography with focused ultrasound",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      MRI of the breast is useful for evaluation.",
"     </li>",
"     <li>",
"      Patients who have had breast conservation should resume surveillance with mammography annually. If suspicious findings are found on mammography, focused ultrasound",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      MRI is useful for evaluation.",
"     </li>",
"     <li>",
"      For patients at higher risk for metastatic disease (eg, tumors &gt;5 cm), surveillance may be performed more frequently. In addition, these high risk patients are followed with chest CT scans every six months for two years, and then annually.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Phyllodes tumors are uncommon fibroepithelial breast tumors that are capable of a diverse range of biologic behavior. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most phyllodes tumors present as smooth, multinodular, painless breast lumps. While they can be confused with fibroadenomas, suspicion for a phyllodes tumor should be increased with large tumor size and rapid growth. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical presentation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The typical appearance of a phyllodes tumor on mammography is a smooth, polylobulated mass. On ultrasound examination, these lesions are solid, hypoechoic and, well circumscribed. The presence of cystic areas within the mass may increase the level of suspicion for phyllodes tumors. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical presentation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A core biopsy of a suspicious mass should be performed. Fine needle aspiration is not a sufficient diagnostic test. If the results are indeterminate, excisional biopsy should be completed. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical presentation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Histologically, phyllodes tumors are classified as benign, borderline or malignant. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend wide local excision, with a margin of at least 1 cm for phyllodes tumors as opposed to enucleation or local excision alone (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Recurrence rates are unacceptably high following either local excision or enucleation without adequate margins. Breast conservation does not compromise cancer-specific survival. Mastectomy can be reserved for cases where breast conservation cannot be achieved with an acceptable cosmetic result. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest not performing axillary dissection for phyllodes tumors (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Axillary lymph node involvement is rarely reported, even with malignant tumors. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest not performing adjuvant radiotherapy for benign phyllodes tumors that are widely excised (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Chemotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest adjuvant radiotherapy for borderline or malignant phyllodes tumors (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Radiation substantially reduces the recurrence rate of these tumors, particularly if it is not possible to obtain a wide margin of &ge;1 cm of resection. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that adjuvant chemotherapy should be reserved for patients with large, high-risk or recurrent malignant tumors (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that hormonal therapy not be used for phyllodes tumors (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Calhoun K, Lawton TJ, Kim JM, et al. Phyllodes tumors. In: Diseases of the breast, Harris J, Lippman ME, Osborne CK, Morrow M (Eds), Lippincott Williams and Wilkins, 2010 2010. p.781.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/2\">",
"      Chaney AW, Pollack A, McNeese MD, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000; 89:1502.",
"     </a>",
"    </li>",
"    <li>",
"     Tavassoli FA, Devilee P. and genetics of tumours of the breast and female genital organs. In: World Health Organization Classification of Tumours, IARC Press, Lyons 2003. p.99.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/4\">",
"      Reinfuss M, Mitu�� J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 1996; 77:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/5\">",
"      Geisler DP, Boyle MJ, Malnar KF, et al. Phyllodes tumors of the breast: a review of 32 cases. Am Surg 2000; 66:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/6\">",
"      Bernstein L, Deapen D, Ross RK. The descriptive epidemiology of malignant cystosarcoma phyllodes tumors of the breast. Cancer 1993; 71:3020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/7\">",
"      Norris HJ, Taylor HB. Relationship of histologic features to behavior of cystosarcoma phyllodes. Analysis of ninety-four cases. Cancer 1967; 20:2090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/8\">",
"      Barrio AV, Clark BD, Goldberg JI, et al. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol 2007; 14:2961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/9\">",
"      Karim RZ, Gerega SK, Yang YH, et al. Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast 2009; 18:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/10\">",
"      Birch JM, Alston RD, McNally RJ, et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 2001; 20:4621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/11\">",
"      Kuijper A, Buerger H, Simon R, et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J Pathol 2002; 197:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/12\">",
"      Telli ML, Horst KC, Guardino AE, et al. Phyllodes tumors of the breast: natural history, diagnosis, and treatment. J Natl Compr Canc Netw 2007; 5:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/13\">",
"      Macdonald OK, Lee CM, Tward JD, et al. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer 2006; 107:2127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/14\">",
"      Mangi AA, Smith BL, Gadd MA, et al. Surgical management of phyllodes tumors. Arch Surg 1999; 134:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/15\">",
"      Wurdinger S, Herzog AB, Fischer DR, et al. Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol 2005; 185:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/16\">",
"      Yabuuchi H, Soeda H, Matsuo Y, et al. Phyllodes tumor of the breast: correlation between MR findings and histologic grade. Radiology 2006; 241:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/17\">",
"      Farria DM, Gorczyca DP, Barsky SH, et al. Benign phyllodes tumor of the breast: MR imaging features. AJR Am J Roentgenol 1996; 167:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/18\">",
"      Jacklin RK, Ridgway PF, Ziprin P, et al. Optimising preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol 2006; 59:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/19\">",
"      El Hag IA, Aodah A, Kollur SM, et al. Cytological clues in the distinction between phyllodes tumor and fibroadenoma. Cancer Cytopathol 2010; 118:33.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/21\">",
"      Dillon MF, Quinn CM, McDermott EW, et al. Needle core biopsy in the diagnosis of phyllodes neoplasm. Surgery 2006; 140:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/22\">",
"      Lee AH. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology 2008; 52:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/23\">",
"      Lee AH, Hodi Z, Ellis IO, Elston CW. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology 2007; 51:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/24\">",
"      Carter BA, Page DL. Phyllodes tumor of the breast: local recurrence versus metastatic capacity. Hum Pathol 2004; 35:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/25\">",
"      de Roos WK, Kaye P, Dent DM. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast. Br J Surg 1999; 86:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/26\">",
"      Hawkins RE, Schofield JB, Fisher C, et al. The clinical and histologic criteria that predict metastases from cystosarcoma phyllodes. Cancer 1992; 69:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/27\">",
"      Fajdi�� J, Gotovac N, Hrgovi�� Z, et al. Phyllodes tumors of the breast diagnostic and therapeutic dilemmas. Onkologie 2007; 30:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/28\">",
"      Parker SJ, Harries SA. Phyllodes tumours. Postgrad Med J 2001; 77:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/29\">",
"      Barth RJ Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat 1999; 57:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/30\">",
"      Belkac&eacute;mi Y, Bousquet G, Marsiglia H, et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys 2008; 70:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/31\">",
"      Pietruszka M, Barnes L. Cystosarcoma phyllodes: a clinicopathologic analysis of 42 cases. Cancer 1978; 41:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/32\">",
"      Powell CM, Rosen PP. Adipose differentiation in cystosarcoma phyllodes. A study of 14 cases. Am J Surg Pathol 1994; 18:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/33\">",
"      Guerrero MA, Ballard BR, Grau AM. Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth. Surg Oncol 2003; 12:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/34\">",
"      Confavreux C, Lurkin A, Mitton N, et al. Sarcomas and malignant phyllodes tumours of the breast--a retrospective study. Eur J Cancer 2006; 42:2715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/35\">",
"      Jang JH, Choi MY, Lee SK, et al. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast. Ann Surg Oncol 2012; 19:2612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/36\">",
"      Barth RJ Jr, Wells WA, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol 2009; 16:2288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/37\">",
"      Kapiris I, Nasiri N, A'Hern R, et al. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol 2001; 27:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/38\">",
"      Chen WH, Cheng SP, Tzen CY, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol 2005; 91:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/39\">",
"      Bhargav PR, Mishra A, Agarwal G, et al. Phyllodes tumour of the breast: clinicopathological analysis of recurrent vs. non-recurrent cases. Asian J Surg 2009; 32:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/40\">",
"      Soumarov&aacute; R, Seneklov&aacute; Z, Horov&aacute; H, et al. Retrospective analysis of 25 women with malignant cystosarcoma phyllodes--treatment results. Arch Gynecol Obstet 2004; 269:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/41\">",
"      Pezner RD, Schultheiss TE, Paz IB. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys 2008; 71:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/42\">",
"      Morales-V&aacute;squez F, Gonzalez-Angulo AM, Broglio K, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast. Breast J 2007; 13:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/43\">",
"      Burton GV, Hart LL, Leight GS Jr, et al. Cystosarcoma phyllodes. Effective therapy with cisplatin and etoposide chemotherapy. Cancer 1989; 63:2088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/44\">",
"      Sapino A, Bosco M, Cassoni P, et al. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol 2006; 19:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/45\">",
"      Tse GM, Lee CS, Kung FY, et al. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor: a multicenter study of 143 cases. Am J Clin Pathol 2002; 118:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/46\">",
"      Allen R, Nixon D, York M, Coleman J. Successful chemotherapy for cystosarcoma phyllodes in a young woman. Arch Intern Med 1985; 145:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/47\">",
"      Kessinger A, Foley JF, Lemon HM, Miller DM. Metastatic cystosarcoma phyllodes: a case report and review of the literature. J Surg Oncol 1972; 4:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/48\">",
"      Hawkins RE, Schofield JB, Wiltshaw E, et al. Ifosfamide is an active drug for chemotherapy of metastatic cystosarcoma phyllodes. Cancer 1992; 69:2271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/49\">",
"      Patel SR, Zagars GK, Pisters PW. The follow-up of adult soft-tissue sarcomas. Semin Oncol 2003; 30:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18424/abstract/50\">",
"      Grabowski J, Salzstein SL, Sadler GR, Blair SL. Malignant phyllodes tumors: a review of 752 cases. Am Surg 2007; 73:967.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 793 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-794AB5B1AF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18424=[""].join("\n");
var outline_f17_63_18424=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL PRESENTATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Surgical resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      ADVANCED AND RECURRENT DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Local recurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14605481\">",
"      SURVEILLANCE AFTER THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/793\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/793|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/25/40339\" title=\"figure 1\">",
"      Histology phyllodes tumor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/793|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/12/14532\" title=\"picture 1\">",
"      Gross phyllodes tumor",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/11/14521?source=related_link\">",
"      Adjuvant and neoadjuvant chemotherapy for soft tissue sarcoma of the extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/59/24504?source=related_link\">",
"      Breast biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39482?source=related_link\">",
"      Breast imaging: Mammography and ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44025?source=related_link\">",
"      Characteristics of hereditary breast and ovarian cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/36/24138?source=related_link\">",
"      Diagnostic evaluation of women with suspected breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/6/12391?source=related_link\">",
"      Li-Fraumeni syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/47/38650?source=related_link\">",
"      Local treatment for primary soft tissue sarcoma of the extremities and chest wall",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/52/11081?source=related_link\">",
"      Overview of benign breast disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/7/11385?source=related_link\">",
"      Role of radiation therapy in breast conservation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/40/44680?source=related_link\">",
"      Surgical treatment and other localized therapy for metastatic soft tissue sarcoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_63_18425="Blunt genitourinary trauma";
var content_f17_63_18425=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Blunt genitourinary trauma",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18425/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18425/contributors\">",
"     Michael S Runyon, MD, FAAEM, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18425/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18425/contributors\">",
"     Maria E Moreira, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18425/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18425/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18425/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/63/18425/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Timely identification and management of blunt genitourinary injuries minimize associated morbidity, which may include impairment of urinary continence and sexual function. Prompt injury identification depends upon a systematic evaluation with consideration of the mechanism of injury, pertinent physical examination findings, analysis of the urine, and appropriate diagnostic imaging, performed in the correct sequence.",
"   </p>",
"   <p>",
"    Except in the rare instance of a shattered kidney or major renal vascular laceration with significant hemorrhage, genitourinary injuries seldom pose a threat to life. Once life-threatening conditions are stabilized, investigation for genitourinary injury is conducted in a retrograde fashion beginning with evaluation of the external genitalia and urethra prior to that of the bladder. The ureters and kidneys are evaluated after lower tract injury is excluded, or after initiation of appropriate emergency management for an identified lower tract injury.",
"   </p>",
"   <p>",
"    This topic review will discuss the diagnosis and management of genitourinary injury sustained through blunt trauma. Discussions of general trauma management and other specific injuries are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=see_link\">",
"     \"Initial management of trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=see_link\">",
"     \"Initial evaluation and management of blunt abdominal trauma in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=see_link\">",
"     \"Pelvic trauma: Initial evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 percent of patients suffering injuries severe enough to require admission to a trauma service sustain injury to the genitourinary tract. The majority of these injuries (approximately 80 percent) result from blunt trauma. Common mechanisms of injury include motor vehicle collisions (MVC), falls from height, and direct blows to the torso or external genitalia. Injuries to the female genitalia are often associated with pelvic fractures.",
"   </p>",
"   <p>",
"    Other important mechanisms include physical or sexual assault, consensual intercourse, and penetrating injuries. In the adult patient, isolated blunt injury to the vulva is unusual and should prompt screening for interpersonal violence. In men, up to 85 percent of testicular injuries result from blunt trauma. Resultant injuries include hematoma, rupture, displacement, and torsion. Penile fracture is an uncommon injury resulting from rupture of the tunica albuginea, with concomitant urethral injury occurring in up to 20 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Overall, urethral disruption accompanies pelvic fracture in approximately five percent of cases in women and up to 25 percent in men; risk varies with the extent of the fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Blunt injury accounts for the majority of bladder trauma and a pelvic fracture accompanies most cases of bladder rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/1,6\">",
"     1,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The kidney is the most commonly injured genitourinary organ. Due to the significant forces required, associated intraabdominal injuries occur commonly [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/7\">",
"     7",
"    </a>",
"    ]. Most renal injuries result from blunt trauma and tend to be less severe overall, with a lower nephrectomy rate than those seen with penetrating injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/1\">",
"     1",
"    </a>",
"    ]. Ureteral injury is rare, comprising less than one percent of all genitourinary injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY, PHYSIOLOGY, AND MECHANISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anatomically, the genitourinary system is divided into the upper and lower tracts (",
"    <a class=\"graphic graphic_figure graphicRef83478 \" href=\"UTD.htm?2/6/2152\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83479 \" href=\"UTD.htm?11/40/11913\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83477 \" href=\"UTD.htm?10/36/10825\">",
"     figure 3",
"    </a>",
"    ). Specific mechanisms lead to injury in different parts of the system. The lower genitourinary tract consists of the external genitalia, urethra, and bladder (",
"    <a class=\"graphic graphic_figure graphicRef83293 \" href=\"UTD.htm?41/22/42345\">",
"     figure 4",
"    </a>",
"    ). The upper tract consists of the ureters and the kidneys.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      External genitalia &ndash; The male external genitalia consist of the penis, scrotum, testicles, and the ejaculatory complex (",
"      <a class=\"graphic graphic_figure graphicRef83293 \" href=\"UTD.htm?41/22/42345\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef74328 \" href=\"UTD.htm?43/32/44546\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef75672 \" href=\"UTD.htm?32/1/32786\">",
"       figure 5",
"      </a>",
"      ). The female external genitalia consist of the vulva and vagina and includes the labia majora, labia minora, and the clitoris (",
"      <a class=\"graphic graphic_figure graphicRef62557 \" href=\"UTD.htm?26/23/26995\">",
"       figure 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef83640 \" href=\"UTD.htm?10/12/10441\">",
"       figure 7",
"      </a>",
"      ). Injuries to the external genitalia may occur by blunt mechanisms such as a direct blow, a fall from height, or a straddle injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35669?source=see_link\">",
"       \"Straddle injuries\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Injury may also occur by circulatory compromise inflicted by constricting objects applied either accidentally (eg, hair tourniquet) or intentionally to enhance sexual performance and pleasure. Penile fracture occurs when the erect penis is bent suddenly and forcefully, rupturing the tunica albuginea of one or both of the corpora cavernosa. This occurs most commonly during sexual intercourse when the penis slips out of the vagina and strikes the partner's pubis or perineum, but may also occur during masturbation [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/2,9\">",
"       2,9",
"      </a>",
"      ]. Significant injury to the external genitalia may accompany pelvic fractures.",
"     </li>",
"     <li>",
"      Urethra &ndash; The male urethra is divided into the anterior (bulbous and pendulous) and posterior (prostatic and membranous) urethra. Traditionally, this division was described at the level of the urogenital diaphragm; however, some researchers have questioned the existence of this anatomic structure [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/5,10,11\">",
"       5,10,11",
"      </a>",
"      ]. Regardless, the weakest point of the posterior urethra is the bulbomembranous junction, where the majority of posterior urethral disruptions occur [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/5\">",
"       5",
"      </a>",
"      ]. Anterior urethra injuries may be inflicted by direct blows, straddle injuries, instrumentation, or in conjunction with a penile fracture. By contrast, posterior urethral injuries usually occur in the setting of significant pelvic fractures, often caused by motor vehicle collisions (MVC). Urethral injuries are much less common in women because the urethra is short, relatively mobile, and lacks significant attachment to the pubis.",
"     </li>",
"     <li>",
"      Bladder &ndash; When empty, the bladder lies along the floor of the pelvis where it remains relatively protected, unless the force of injury fractures the bony pelvis. When distended by urine, the bladder may extend up to the level of the umbilicus where it is vulnerable to blunt trauma inflicted upon the lower abdomen. The weakest and most mobile area of the bladder is at the peritoneal surface of the dome.",
"      <br/>",
"      <br/>",
"      Blunt force bladder injuries are seen with lower abdominal trauma and in conjunction with pelvic fractures, often resulting from a MVC. They are classified as a contusion, intraperitoneal rupture, or extraperitoneal rupture. Contusions are partial thickness injuries to the bladder wall without rupture. Intraperitoneal rupture occurs from a blunt force injury to the lower abdomen in a patient with a full bladder and results in rupture at the bladder dome followed by extravasation of urine into the peritoneal cavity. Extraperitoneal rupture most often occurs in association with a pelvic fracture. The injuring force causes rupture at the anterior or anterolateral wall. In other cases, bony fragments from a pelvic fracture impale the bladder causing extraperitoneal rupture.",
"     </li>",
"     <li>",
"      Kidneys and ureters &ndash; The kidneys lie in the retroperitoneal space and are protected by the lower ribs, the back musculature, and the perinephric fat. The right kidney extends lower than the left due to the presence of the liver. Significant force is required to injure the kidney. MVCs, falls, direct blows, and lower rib fractures are common mechanisms. Significant decelerating forces may cause avulsion of the renal pedicle or renal artery dissection. In children, bicycle accidents represent a prominent mechanism of renal injury [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/12\">",
"       12",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The ureters course distally along the psoas muscles and enter the bladder posteriorly and inferiorly at the trigone. The adjacent musculature and the bony pelvis provide the ureters a degree of protection from injury. The majority (75 percent) of ureteral injuries are iatrogenic, with most occurring during gynecologic, general surgical, or urologic operative or ureteroscopic procedures. Of the remaining injuries, approximately one-third are inflicted by blunt trauma [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/8\">",
"       8",
"      </a>",
"      ]. The most common blunt mechanism is a significant deceleration force with avulsion at the ureteropelvic junction, resulting from a MVC or fall from height. This injury is more common in children due to the increased mobility of the vertebral column [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREHOSPITAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prehospital management of the patient with blunt genitourinary trauma should focus on identification and stabilization of any potential life threats. Suspected open-book pelvic fractures should be stabilized with an external compression device, which may be as simple as a tightly wrapped sheet. Prehospital management of the trauma patient is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=see_link\">",
"     \"Prehospital care of the adult trauma patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;When possible, obtain a focused history of the injury from the patient, prehospital personnel, and available bystanders. Important information relevant to genitourinary injury includes the mechanism of injury, prehospital care, and any previous history of genitourinary injury or disease. As the",
"    <strong>",
"     genitourinary tract is seldom injured in isolation",
"    </strong>",
"    , a meticulous physical examination is crucial to avoid missing occult injuries.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      External genitalia injury &ndash; Blunt scrotal trauma may result in superficial ecchymosis and swelling or testicular rupture, torsion, or displacement. In testicular rupture, the tunica albuginea is disrupted. Even in the absence of testicular rupture, blood or fluid may accumulate between the tunica albuginea and tunica vaginalis resulting in a hematocele. Testicular torsion disrupts the vascular supply and causes ischemia. Testicular displacement occurs when the testicle is forced from the scrotum, usually into the peritoneal cavity. With these injuries, physical examination may be limited by pain and swelling.",
"      <br/>",
"      <br/>",
"      Penile fracture is often accompanied by an audible snap and followed immediately by severe pain, detumescence, swelling, and ecchymosis. The corpus spongiosum is involved in 20 to 30 percent of cases and urethral injury occurs in 10 to 20 percent. If Buck's fascia remains intact, the swelling and ecchymosis are confined to the penile shaft. If not, blood and urine may dissect into the scrotum, perineum, and suprapubic spaces [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/2,13\">",
"       2,13",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In the presence of a pelvic fracture or blood at the introitus, the clinician must perform meticulous vaginal and rectal examinations. The complications of missed vaginal injuries include infection, fistula formation, and significant hemorrhage [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. In one small case series, 25 percent of women sustaining injury of the external genitalia required red cell transfusion due to blood loss from genital injury alone [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/14\">",
"       14",
"      </a>",
"      ]. If a pelvic fracture is present or suspected, the examiner should take care to avoid penetrating injury to the examining hand from bone edges or fragments when performing a vaginal or rectal examination.",
"      <br/>",
"      <br/>",
"      Trauma to the lower genital tract in women, including injuries sustained from sexual assault, is reviewed in greater detail separately. Genital injuries in children sustained via sexual abuse are also reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link&amp;anchor=H2#H2\">",
"       \"Evaluation and management of lower genital tract trauma in women\", section on 'Etiology'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link&amp;anchor=H6#H6\">",
"       \"Evaluation and management of lower genital tract trauma in women\", section on 'Physical examination'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link\">",
"       \"Evaluation of sexual abuse in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urethra and bladder injury &ndash; The signs and symptoms of urethral injury include blood at the urethral meatus, gross hematuria, inability to void, an absent or abnormally positioned prostate on digital rectal examination, or ecchymosis or hematoma involving the penis, scrotum, or perineum. Unfortunately, these classic findings may be absent in up to 57 percent of urethral injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/16\">",
"       16",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      With pelvic fractures, the risk of urethral injury varies with fracture type [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/5,16-20\">",
"       5,16-20",
"      </a>",
"      ]. High risk injuries include concomitant fractures of all four pubic rami or fractures of both ipsilateral rami accompanied by massive posterior disruption through the sacrum, sacroiliac joint, or ilium. Low risk injuries include single ramus fractures and ipsilateral rami fractures without posterior ring disruption. The risk of urethral injury approaches zero with isolated fractures of the acetabulum, ilium, and sacrum [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/5\">",
"       5",
"      </a>",
"      ].Posterior urethral disruption occurs when a significant pelvic fracture causes upward displacement of the bladder and prostate. Avulsion of the puboprostatic ligament is followed by stretching of the membranous urethra resulting in a partial or complete disruption at the anatomic weak point, the bulbomembranous junction [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomy, physiology, and mechanism'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Greater than two thirds of blunt bladder injuries present with gross hematuria, with or without pelvic fracture. Microhematuria, defined here as &ge;25 red blood cells",
"      <span class=\"nowrap\">",
"       (RBC)/high-powered",
"      </span>",
"      field (HPF), is present in nearly all remaining cases; fewer than 1 percent of all blunt bladder injuries present with a urinalysis containing &lt;25",
"      <span class=\"nowrap\">",
"       RBCs/HPF",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/21-23\">",
"       21-23",
"      </a>",
"      ]. Bladder injury may occur with any pelvic fracture, but is more likely with fractures of the anterior arch or when all four pubic rami are fractured. Additional signs and symptoms include lower abdominal pain or tenderness and inability to void.",
"     </li>",
"     <li>",
"      Upper genitourinary tract injury &ndash; The clinical clues to a potential renal injury are nonspecific, but include: bruising, pain, or tenderness to the flank or abdomen; posterior rib or spine fractures; gross hematuria; other organ injury; microhematuria, defined as &ge;3 to 5",
"      <span class=\"nowrap\">",
"       RBCs/HPF;",
"      </span>",
"      and shock, defined as a systolic blood pressure &le;90 mmHg. Hematuria (gross or microscopic) is",
"      <strong>",
"       NOT",
"      </strong>",
"      a sensitive predictor of ureteral injury, as the urinalysis is normal approximately 25 percent of the time [",
"      <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/24\">",
"       24",
"      </a>",
"      ]. Ureteral injury is frequently missed during the initial evaluation as the signs and symptoms are minimal and nonspecific. Delayed findings include fever, flank pain, and a palpable flank mass (urinoma).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PRIMARY EVALUATION AND MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Initial assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with any emergency department (ED) patient, the initial assessment of the patient with blunt genitourinary trauma should focus on the rapid identification and stabilization of life-threatening injuries. Genitourinary trauma is rarely life-threatening, although a shattered kidney, major renal vascular laceration with significant hemorrhage, and renal artery dissection or avulsion of the pedicle from significant deceleration can pose a threat to life or to the kidney itself. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=see_link\">",
"     \"Initial management of trauma in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the multiply injured or unstable patient, evaluation for genitourinary injury is deferred until potentially life-threatening injuries are excluded and the patient is stabilized. Findings that may herald genitourinary injury, such as gross hematuria or pelvic fracture, are noted so appropriate investigation may be undertaken once immediate life threats have been addressed.",
"   </p>",
"   <p>",
"    Standard trauma management should be implemented. Apply dressings to open wounds and control any ongoing hemorrhage with direct pressure. Place a pelvic stabilization device (prefabricated pelvic binder, or a bed sheet tied tightly around the pelvis) on any potentially unstable pelvic fracture that may be contributing to hemodynamic instability. This is particularly important with \"open-book\" type pelvic fractures (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53056 \" href=\"UTD.htm?43/5/44112\">",
"     image 1",
"    </a>",
"    ). Administer intravenous fluids, blood products, analgesics, and tetanus immunization as needed. Nothing is given to the patient by mouth until the need for operative intervention has been excluded.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     History, examination, and approach to testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic teaching holds that the digital rectal examination provides useful clinical information in the blunt trauma patient with an associated pelvic fracture or suspected urethral injury. The rectal examination includes evaluation for an absent or \"high riding\" prostate, which may be associated with a posterior urethral disruption and suggests the need for a prompt investigation of urethral integrity. However, in most instances, other clinical indicators of possible urologic injury are present, such as a scrotal or perineal hematoma or blood at the urethral meatus. Furthermore, multiple retrospective studies suggest that the digital rectal examination is not useful for detecting urethral injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. As such, when deciding to evaluate for urethral injury, the clinician should consider additional clinical features including the mechanism of injury and the presence and type of any pelvic fracture and not rely solely on the findings of the digital rectal examination.",
"   </p>",
"   <p>",
"    While most multiply injured patients receive a digital rectal examination, the vaginal examination is often erroneously omitted. To avoid missing occult injuries that may result in significant hemorrhage and infection, clinicians should perform a meticulous vaginal examination in all injured women with pelvic fractures to assess for lacerations or bone fragments. This is especially critical in patients with displaced fractures of the anterior pelvic ring, but less so in those with an isolated, unilateral pubic ramus fracture. Clinicians should take care to avoid penetrating injury to the examining hand from bone fragments.",
"   </p>",
"   <p>",
"    The diagnosis of injuries to external genitalia is largely based on the mechanism of injury and the physical examination. Unexplained penile or clitoral swelling necessitates a careful search for a hair tourniquet, especially in infants and young children. Consider concomitant urethral injury and perform a retrograde urethrogram to assess urethral integrity in any patient with blood at the urethral meatus, gross hematuria, or ecchymosis or hematoma involving the external genitalia. Plain films revealing a pelvic fracture should prompt a careful examination for occult colorectal or vaginal injury.",
"   </p>",
"   <p>",
"    In cases of suspected urethral injury, classic teaching held that it is imperative to evaluate the integrity of the urethra by retrograde urethrogram prior to attempting placement of a Foley (ie, bladder or urinary) catheter to avoid worsening a partial disruption. &nbsp;While the literature on this topic is sparse, one small retrospective review of thirteen cases of urethral injury found no evidence that a blind attempt to insert a urinary catheter worsened the initial injury [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/28\">",
"     28",
"    </a>",
"    ]. As such, in the presence of gross hematuria without other signs of urethral injury, it is reasonable to make one attempt at passing a Foley catheter. If resistance is encountered, abort the attempt and investigate urethral integrity by retrograde urethrography. Placement and management of urinary catheters is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/47/40697?source=see_link\">",
"     \"Placement and management of urinary bladder catheters\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a Foley catheter has been placed, evaluate all patients with gross hematuria, and those with a pelvic fracture and microscopic hematuria (defined here as &ge;25 red blood cells",
"    <span class=\"nowrap\">",
"     (RBC)/high-powered",
"    </span>",
"    field (HPF)), for bladder rupture. This is accomplished by retrograde cystography or retrograde CT cystography. Retrograde urethrography or cystography should be deferred, however, when significant pelvic vascular injury is suspected as extravasated contrast dye from the retrograde urethrogram or cystogram may obscure computed tomography and angiography images thereby interfering with study interpretation and subsequent embolization attempts [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Renal imaging is indicated in blunt injuries in the presence of gross hematuria or microscopic hematuria (&ge;3 to 5",
"    <span class=\"nowrap\">",
"     RBCs/HPF)",
"    </span>",
"    with shock (defined as systolic blood pressure less than 90 mmHg). Additional relative indications include a significant decelerating mechanism, such as a high speed MVC or a fall from height [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/7,30\">",
"     7,30",
"    </a>",
"    ]. The imaging study of choice is CT scanning with intravenous contrast. In the hemodynamically stable patient with suspected renal injury, contrast-enhanced CT scanning is also used to evaluate for the presence and extent of the injury. Delayed CT images are needed in cases of suspected renal collecting system injury.",
"   </p>",
"   <p>",
"    The diagnosis of ureteral injury is elusive. Intravenous pyelography has long been the test of choice, although the reported sensitivity ranges from 25 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/24\">",
"     24",
"    </a>",
"    ]. CT imaging is often performed for identification of related injuries. Additional delayed CT images of the renal collecting system (obtained 10 minutes after contrast injection) are indicated when the initial images are nondiagnostic in a patient with suspected injury to the renal collecting system. The delay allows time for the intravenous contrast to be excreted by the kidneys. If operative exploration is indicated, the ureters may be directly evaluated in the surgical suite. When the diagnosis remains in doubt, retrograde pyelography may be of use.",
"   </p>",
"   <p>",
"    Trauma to the lower genital tract in women, including injuries sustained from sexual assault, is reviewed in greater detail separately. Genital injuries in children sustained via sexual abuse are also reviewed separately. A complete examination of the traumatized lower GU tract of an infant or child may need to be performed by a clinician with suitable expertise under general anaesthesia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation and management of lower genital tract trauma in women\", section on 'Etiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link&amp;anchor=H6#H6\">",
"     \"Evaluation and management of lower genital tract trauma in women\", section on 'Physical examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diagnostic tests",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematuria is an important marker for potential injury to the GU tract. When possible, inspect the initial urine output to avoid missing transient hematuria that may clear with ongoing fluid resuscitation. A spontaneously voided specimen is ideal, but is frequently impractical in the multiply injured patient.",
"   </p>",
"   <p>",
"    Gross hematuria is defined as urine that is any color other than clear or yellow. This necessarily conservative definition is clinically important as the degree of gross hematuria does",
"    <strong>",
"     NOT",
"    </strong>",
"    correlate with the severity of injury: a relatively minor urethral injury may result in impressive hemorrhage while major vascular disruption may present with only slightly discolored urine. False positives may result from many factors including ingestion of certain food products or dyes, select medications, or the presence of free myoglobin due to rhabdomyolysis.",
"   </p>",
"   <p>",
"    Microscopic hematuria is generally defined as &ge;3 to 5 red blood cells per high powered field",
"    <span class=\"nowrap\">",
"     (RBCs/HPF)",
"    </span>",
"    or a positive dipstick evaluation. The significance of gross versus microscopic hematuria varies with the age of the patient and with the location (kidney, ureter, bladder, or urethra) and mechanism of injury (blunt versus penetrating). Thus different thresholds for microscopic hematuria are used to determine management according to clinical circumstance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Plain x-rays",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the initial assessment and stabilization, and depending on the specific mechanism of injury, plain x-rays may provide information about associated injuries that may be markers for potential genitourinary trauma. Such injuries include: low posterior rib fractures on chest x-ray, vertebral and transverse process fractures on spine or chest radiographs, and pelvic fractures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Retrograde urethrogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;In cases of suspected urethral injury, the integrity of the urethra is investigated by retrograde urethrogram. However, the procedure is deferred if significant pelvic vascular injury is suspected or when pelvic angiography is indicated for any reason. This is because assessment for potentially life-threatening injuries takes precedence and because the contrast used to perform a retrograde urethrogram may interfere with the interpretation of a pelvic angiogram or CT scan. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'History, examination, and approach to testing'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The procedure is performed as follows. Keep the patient supine and still to avoid potentially disrupting a stable pelvic hematoma. Obtain a baseline abdominal radiograph (KUB) and ensure the film captures the entire course of the urethra and bladder. Retract the foreskin, if present, and control the shaft of the penis with a 4 by 4 inch gauze pad to prevent slippage. Stretch the penis obliquely over the thigh to promote unfolding and visualization of the entire urethra. Fill a 60 mL syringe with 10 percent water-soluble contrast (diluted in sterile saline) and attach a Christmas tree adaptor. Insert the adaptor snugly into the urethral meatus ensuring a tight fit as leaking contrast will result in a spurious study.",
"   </p>",
"   <p>",
"    Alternatively, insert a Foley (ie, bladder or urinary) catheter a few centimeters into the urethra and partially inflate the balloon to ensure a snug fit within the fossa navicularis. Attach a catheter-tip syringe filled with contrast as above. Inject 50 to 60 mL (0.6",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    in children) of contrast and obtain a KUB during infusion of the final 10 mL. Lack of urethral extravasation with contrast entering the bladder defines a normal study. A partial disruption is demonstrated by urethral extravasation accompanied by contrast entering the bladder. A complete disruption results in urethral extravasation with no contrast entering the bladder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Retrograde cystogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once urethral injury is excluded",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a Foley (ie, bladder or urinary) catheter has been placed, evaluate all stable patients with gross hematuria or pelvic fracture for bladder rupture using retrograde cystography or retrograde CT cystography.",
"   </p>",
"   <p>",
"    As with the retrograde urethrogram, keep the patient supine and still to avoid potentially disrupting a stable pelvic hematoma and take care to avoid contrast spillage which will result in a spurious study. Obtain a baseline abdominal radiograph (KUB). Remove the central piston from a 60 mL catheter-tip syringe and attach it to the Foley catheter. Hold the syringe upright above the level of the bladder and instill 400 mL of 10 percent water-soluble contrast (diluted in sterile saline) by gravity. In patients younger than 11 years, calculate the appropriate amount of contrast in mL using the formula: (age in years + 2) x 30.",
"   </p>",
"   <p>",
"    If the bladder contracts prior to instillation of 400 mL (as demonstrated by the contrast level rising in the barrel of the syringe), wait for the contraction to pass and refill the bladder to the point of contraction, then forcefully inject another 50 mL of contrast. The goal is to distend the bladder adequately to ensure extravasation when rupture is present. The most common reason for false-negative cystography is failure to instill sufficient contrast.",
"   </p>",
"   <p>",
"    After filling the bladder, clamp the catheter and obtain a KUB. After ensuring adequacy of the contrast study, unclamp the catheter, allow the bladder to drain, and obtain a postevacuation film. Extraperitoneal rupture appears as flame-like areas of contrast confined to the pelvis, often extending lateral to the bladder (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57018 \" href=\"UTD.htm?24/40/25217\">",
"     image 2",
"    </a>",
"    ). Intraperitoneal rupture appears as contrast outlining bowel and other structures in the peritoneal cavity. Using the baseline film for comparison, carefully scrutinize the postevacuation study for any subtle areas of extravasation not seen on the contrast-distended view.",
"   </p>",
"   <p>",
"    For retrograde CT cystography, the bladder is filled in an identical manner (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67699 \" href=\"UTD.htm?18/12/18630\">",
"     image 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66210 \" href=\"UTD.htm?41/58/42914\">",
"     image 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76956 \" href=\"UTD.htm?34/9/34963\">",
"     image 5",
"    </a>",
"    ). Do",
"    <strong>",
"     NOT",
"    </strong>",
"    simply clamp the Foley catheter and rely on passive filling of the bladder by intravenously administered contrast for CT cystography. Multiple studies have demonstrated missed injuries using this approach [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/6,7,31,32\">",
"     6,7,31,32",
"    </a>",
"    ]. A postevacuation film is not necessary with retrograde CT cystography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     CT scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT scanning with intravenous contrast enhancement is the modality of choice for the identification and staging of renal trauma in the hemodynamically stable patient (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81694 \" href=\"UTD.htm?7/61/8148\">",
"     image 6",
"    </a>",
"    ). The initial CT images will frequently miss injuries to the renal pelvis and ureters as sufficient contrast may not yet be present in the collecting system. Additional delayed images are needed to assess for contrast extravasation when these injuries are suspected (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68175 \" href=\"UTD.htm?9/24/9605\">",
"     image 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/1,7\">",
"     1,7",
"    </a>",
"    ]. In patients undergoing CT scanning of other organ systems, suspected bladder injuries may be investigated with CT cystography after retrograde filling of the bladder, as described above. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Retrograde cystogram'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Intravenous pyelography (IVP)",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT has largely supplanted IVP as the imaging modality of choice for suspected renal trauma, but IVP may be useful in select cases, such as suspected ureteral injury when delayed CT images are nondiagnostic. The so-called \"single shot IVP\" is rarely indicated in the emergency department evaluation of suspected blunt renal trauma, but may be used at the discretion of the consulting urologist. The main indication is to confirm the presence of a functioning contralateral kidney in a patient deemed too unstable for transport to the CT scanner. However, this study should never delay transfer to the operating suite in such cases. The procedure is performed by injecting 2",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    of intravenous contrast material and then taking an abdominal x-ray (KUB) 10 minutes later [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/7,33\">",
"     7,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Retrograde pyelography",
"    </span>",
"    &nbsp;&mdash;&nbsp;In select cases, such as suspected ureteral injury when other imaging modalities are nondiagnostic, the operating urologist may elect to perform cystoscopy with retrograde pyelography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is used to evaluate testicular blood flow in cases of suspected torsion (using color and pulsed Doppler) and to supplement the physical examination in cases of testicular trauma. Heterogeneity in the echo pattern of the testicle following trauma is considered diagnostic for testicular rupture. However, this modality is operator dependent with a relatively modest sensitivity and specificity of 64 and 75 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/2,34\">",
"     2,34",
"    </a>",
"    ]. Ultrasound examination of the bladder may reveal free abdominal fluid in the case of an intraperitoneal bladder injury, but ultrasound cannot differentiate urine from blood. For this reason, the focused assessment with sonography for trauma (FAST) examination is less reliable in patients at high risk for bladder injury [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/35\">",
"     35",
"    </a>",
"    ]. Ultrasound lacks sensitivity for renal trauma and should not be relied upon to exclude significant injury [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PEDIATRIC CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kidney injuries are more common in children than adults. This is because the child&rsquo;s kidney is larger relative to the abdomen and pelvis and because the surrounding ribcage, musculature, and relatively scant perinephric fat provide less protection [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/36\">",
"     36",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Controversy exists as to whether the criteria used to determine the need for renal imaging after blunt trauma in adults may be safely applied to children. One issue is whether microscopic hematuria necessitates imaging even in the absence of shock. Consensus guidelines recommend that hemodynamically stable children with blunt trauma should be imaged if they have gross hematuria or &ge;50 red blood cells per high powered field",
"    <span class=\"nowrap\">",
"     (RBCs/HPF)",
"    </span>",
"    on urine microscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/2\">",
"     2",
"    </a>",
"    ]. This is in contrast to the recommendations for hemodynamically stable adults in whom renal imaging is recommended only for those with gross hematuria or in the presence of a significant decelerating injury [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One retrospective review of 720 consecutive pediatric patients with suspected renal trauma, among whom 59 renal injuries were identified, concluded that using the criteria of gross hematuria, shock (ie, systolic blood pressure &lt;90 mmHg), and significant deceleration injury would identify all cases of renal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/37\">",
"     37",
"    </a>",
"    ]. However, pediatric shock and \"significant deceleration injury\" can be difficult to define.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUBSEQUENT MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Remove any constricting devices promptly. This is accomplished by unwinding a hair tourniquet, cutting a tight-fitting constricting ring or band, or by wrapping a string or Penrose drain around the penis distal to the object to decrease swelling and facilitate removal. Liberal use of a water based lubricant may be beneficial. After significant underlying injury has been excluded, superficial lacerations to the scrotum or penis are copiously irrigated and closed with absorbable suture.",
"   </p>",
"   <p>",
"    In patients with a low risk pelvic fracture and no evidence of urethral injury on physical examination, it is reasonable to make one attempt at passage of a Foley (ie, bladder or urinary) catheter. Placement and management of urinary catheters is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/47/40697?source=see_link\">",
"     \"Placement and management of urinary bladder catheters\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Low risk fractures include single ramus fractures and ipsilateral rami fractures without posterior ring disruption. The risk of urethral injury approaches zero with isolated fractures of the acetabulum, ilium, and sacrum. If resistance is met during this single attempt, remove the catheter and obtain a retrograde urethrogram. If the urethra is intact, insert a Foley and inspect the initial output for evidence of hematuria. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Retrograde urethrogram'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    If a urethral injury is suspected subsequent to successful placement of a Foley catheter,",
"    <strong>",
"     do not remove",
"    </strong>",
"    the catheter. A retrograde urethrogram may be obtained by inserting a small feeding tube alongside the catheter and proceeding as above. Urologic consultation is indicated for management of patients with an abnormal urethrogram or in cases of suspected urethral injury when a urethrogram cannot be performed. In females, suspected urethral injury mandates urologic consultation; urethrography is not indicated in the emergency department.",
"   </p>",
"   <p>",
"    With bladder injuries, the primary goal is to keep the bladder completely decompressed, which facilitates healing by minimizing bladder wall tension. If urethral injury is excluded, place a Foley catheter and irrigate the bladder as needed to clear any clots and ensure adequate drainage. Because bladder injuries are frequently associated with intraabdominal trauma, a diligent search for additional injuries should be undertaken in all patients with an abnormal cystogram. When undertaking this search, keep in mind that ultrasound cannot distinguish between blood and urine. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Retrograde cystogram'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'CT scanning'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H17\">",
"     'Ultrasound'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    With upper tract injuries, identification and urologic consultation are the priorities of emergent management.",
"   </p>",
"   <p>",
"    Patients with microscopic hematuria, but without apparent significant genitourinary injury, should be referred for routine outpatient urology follow-up within a few of weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     PITFALLS OF MANAGEMENT",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Delaying transfer to definitive care to obtain imaging studies in the hemodynamically unstable patient.",
"     </li>",
"     <li>",
"      Relying on ultrasound to exclude significant injury in the setting of a grossly abnormal testicle on physical examination.",
"     </li>",
"     <li>",
"      Missing significant injuries due to failure to perform rectal and vaginal examinations in patients with pelvic fractures.",
"     </li>",
"     <li>",
"      Missing significant bladder injuries by clamping the Foley (ie, bladder or urinary) catheter and relying on passive filling of the bladder by intravenously administered contrast prior to CT cystography. An adequate study requires retrograde filling to distend the bladder.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     DEFINITIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with significant genitourinary injuries require urgent or emergent urologic consultation in the emergency department (ED). Many such patients have associated nonurologic injuries that mandate intervention by trauma or general surgeons. In the event that appropriate specialists are unavailable, expeditious transfer to a referral center is necessary following initial assessment and stabilization. Transfer should not be delayed to obtain more detailed imaging in an unstable patient or a patient at risk of decompensating.",
"   </p>",
"   <p>",
"    Some hemodynamically stable patients with minor genitourinary trauma and no other significant injury may be discharged from the ED after a discussion with the urologist assuming responsibility for follow-up care. Such cases include minor lacerations and zipper injuries not requiring formal wound exploration, and isolated, partial, anterior urethral injuries with a functioning Foley (ie, bladder or urinary) catheter in place. Counsel these patients on the signs and symptoms of infection and Foley catheter dysfunction, and ask them to return to the emergency department if they develop these or any other concerning symptoms. Ensure that they understand the importance of complying with the scheduled follow-up plan. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30100?source=see_link\">",
"     \"Management of zipper injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Traumatic testicular torsion and displacement are treated surgically. Early (within 72 hours) operative intervention maximizes the rate of testicular salvage in cases of testicular rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/2\">",
"     2",
"    </a>",
"    ]. Likewise, prompt surgical exploration and repair of penile fractures minimizes the late complications of penile curvature, erectile dysfunction, and dyspareunia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/2,13\">",
"     2,13",
"    </a>",
"    ]. Reimplantation of an amputated penis should be performed as expeditiously as possible, but has been successful after 16 hours of cold ischemia and six hours of warm ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/34\">",
"     34",
"    </a>",
"    ]. The majority of women with vaginal injuries will require operative repair or washout to prevent significant morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=see_link\">",
"     \"Evaluation and management of lower genital tract trauma in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Optimal definitive management of urethral injuries depends on several factors, including: location (anterior or posterior), severity (partial or complete), and the preference and expertise of the consulting urologist. Options vary from placement of a Foley catheter to facilitate healing by secondary intention (for some partial anterior urethral injuries) to early endoscopic realignment or delayed urethroplasty (for posterior urethral injuries). Often, placement of a suprapubic cystostomy tube will be required to promote decompression of the bladder and divert urine from the healing urethral injury or anastomosis. Regardless of the approach, the ultimate goal is the maintenance of urinary continence and sexual function.",
"   </p>",
"   <p>",
"    Operative repair is the rule for most intraperitoneal bladder ruptures. By contrast, the majority of extraperitoneal ruptures can be managed nonoperatively with catheter drainage alone. Exceptions include injuries involving the bladder neck, associated rectal or vaginal injury, and those patients requiring laparotomy for other indications.",
"   </p>",
"   <p>",
"    Depending upon the degree and location of ureteral disruption, management options include cystoscopic stent placement or surgical repair over a stent. Urinary diversion may be required.",
"   </p>",
"   <p>",
"    The need for operative repair of renal trauma depends on the severity of injury, as classified by the American Association for the Surgery of Trauma (AAST) organ injury severity scale for the kidney (",
"    <a class=\"graphic graphic_table graphicRef80576 \" href=\"UTD.htm?7/53/8028\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef57943 \" href=\"UTD.htm?29/5/29784\">",
"     figure 8",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/38\">",
"     38",
"    </a>",
"    ]. Most grade I and II injuries can be managed nonoperatively while grade V injuries frequently require nephrectomy, which in the rare case of exsanguinating hemorrhage from a renal vascular injury may be life-saving.",
"   </p>",
"   <p>",
"    The definitive management of renovascular injuries is a subject of debate among the surgeons who care for these patients. Treatment options vary, depending on hemodynamic stability and associated injuries, and include operative revascularization, nephrectomy, or observation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/39\">",
"     39",
"    </a>",
"    ]. Endovascular stenting may be used to restore arterial flow in cases of renal artery dissection. In cases of major renal vascular disruption, emergent angiography with selective embolization can be both diagnostic and therapeutic. Angiography requires significant time, expertise, and specialized equipment, which is not available in all medical centers. Delayed nephrectomy may be indicated in the small subset of patients who develop hypertension or symptomatic renal infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18425/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Timely recognition and appropriate treatment of genitourinary trauma are paramount to minimizing associated morbidity. Early complications include bleeding, infection, abscess formation, urinary extravasation and fistulas, and urinoma formation. Delayed complications include bleeding, hydronephrosis, calculus formation, chronic pyelonephritis, hypertension, arteriovenous fistulas, pseudoaneurysms, urethral strictures, urinary incontinence, and sexual dysfunction. Acute renal failure may occur, most commonly in the multiply injured patient with hemodynamic instability. A subset of patients will require short term hemodialysis, but the vast majority will regain sufficient renal function to avoid long term dialysis treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specific mechanisms lead to injury in different parts of the genitourinary (GU) system. Timely identification and management of such injuries minimizes associated morbidity, which may include renal insufficiency and impairment of urinary and sexual function. Significant force is required to injure the kidney and associated intraabdominal injuries are common. The GU tract is seldom injured in isolation. The relevant anatomy and the mechanisms and clinical features of specific injuries are described in the text. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Anatomy, physiology, and mechanism'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Injury identification depends upon a systematic evaluation with consideration of the mechanism of injury, pertinent physical examination findings, analysis of the urine, and appropriate diagnostic imaging performed in the correct sequence. Perform a complete physical examination to avoid missing occult injuries. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Primary evaluation and management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Investigate for GU injury in a retrograde fashion beginning with evaluation of the external genitalia and urethra prior to that of the bladder. When urethral injury is suspected and a Foley (ie, bladder or urinary) catheter cannot be easily placed after a single gentle attempt, perform a retrograde urethrogram. In cases of gross hematuria or high-risk pelvic fracture, obtain a retrograde cystogram or retrograde CT cystogram to evaluate for bladder injury. Defer such studies when pelvic angiography is indicated for the diagnosis or management of pelvic hemorrhage. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Primary evaluation and management'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Definitive management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluate the ureters and kidneys (ie, upper tract) after lower tract injury is excluded, or after initiation of appropriate emergency management for an identified lower tract injury. Suspect upper tract injury and obtain an IV contrast enhanced CT scan in patients with gross hematuria, microscopic hematuria (&ge;3 to 5",
"      <span class=\"nowrap\">",
"       RBCs/HPF)",
"      </span>",
"      associated with shock, or injuries sustained from rapid deceleration. Obtain additional, delayed CT images (10 minutes after contrast injection) when the initial images are nondiagnostic in cases of suspected collecting system involvement. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Primary evaluation and management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most patients with significant GU injuries require urgent or emergent urologic consultation. Many patients will have associated nonurologic injuries that mandate surgical consultation. In the event that appropriate specialists are unavailable, expeditious transfer to a referral center is indicated after the initial assessment and stabilization. Do",
"      <strong>",
"       not",
"      </strong>",
"      delay transfer to obtain imaging studies in a patient who is hemodynamically unstable or at risk of decompensation. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Definitive management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2654007\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;We are saddened by the untimely death of John Marx, MD, who passed away in July 2012. We wish to acknowledge Dr. Marx's dedication and his many contributions to UpToDate, in particular, his work as editor-in-chief for Emergency Medicine and as a section editor and author for Adult Trauma.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/1\">",
"      Lynch TH, Mart&iacute;nez-Pi&ntilde;eiro L, Plas E, et al. EAU guidelines on urological trauma. Eur Urol 2005; 47:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/2\">",
"      Morey AF, Metro MJ, Carney KJ, et al. Consensus on genitourinary trauma: external genitalia. BJU Int 2004; 94:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/3\">",
"      Mydlo JH, Harris CF, Brown JG. Blunt, penetrating and ischemic injuries to the penis. J Urol 2002; 168:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/4\">",
"      Chapple CR, Png D. Contemporary management of urethral trauma and the post-traumatic stricture. Curr Opin Urol 1999; 9:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/5\">",
"      Koraitim MM. Pelvic fracture urethral injuries: the unresolved controversy. J Urol 1999; 161:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/6\">",
"      Gomez RG, Ceballos L, Coburn M, et al. Consensus statement on bladder injuries. BJU Int 2004; 94:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/7\">",
"      Vaccaro JP, Brody JM. CT cystography in the evaluation of major bladder trauma. Radiographics 2000; 20:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/8\">",
"      Siram SM, Gerald SZ, Greene WR, et al. Ureteral trauma: patterns and mechanisms of injury of an uncommon condition. Am J Surg 2010; 199:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/9\">",
"      Koifman L, Barros R, J&uacute;nior RA, et al. Penile fracture: diagnosis, treatment and outcomes of 150 patients. Urology 2010; 76:1488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/10\">",
"      Andrich DE, Mundy AR. The nature of urethral injury in cases of pelvic fracture urethral trauma. J Urol 2001; 165:1492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/11\">",
"      Dorschner W, Biesold M, Schmidt F, Stolzenburg JU. The dispute about the external sphincter and the urogenital diaphragm. J Urol 1999; 162:1942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/12\">",
"      Gerstenbluth RE, Spirnak JP, Elder JS. Sports participation and high grade renal injuries in children. J Urol 2002; 168:2575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/13\">",
"      Gottenger EE, Wagner JR. Penile fracture with complete urethral disruption. J Trauma 2000; 49:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/14\">",
"      Goldman HB, Idom CB Jr, Dmochowski RR. Traumatic injuries of the female external genitalia and their association with urological injuries. J Urol 1998; 159:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/15\">",
"      Lev RY, Mor Y, Golomb J, et al. Missed female urethral injury complicated by myonecrosis of the thigh. J Urol 2001; 165:1216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/16\">",
"      Lowe MA, Mason JT, Luna GK, et al. Risk factors for urethral injuries in men with traumatic pelvic fractures. J Urol 1988; 140:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/17\">",
"      Basta AM, Blackmore CC, Wessells H. Predicting urethral injury from pelvic fracture patterns in male patients with blunt trauma. J Urol 2007; 177:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/18\">",
"      Aihara R, Blansfield JS, Millham FH, et al. Fracture locations influence the likelihood of rectal and lower urinary tract injuries in patients sustaining pelvic fractures. J Trauma 2002; 52:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/19\">",
"      Watnik NF, Coburn M, Goldberger M. Urologic injuries in pelvic ring disruptions. Clin Orthop Relat Res 1996; :37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/20\">",
"      Pokorny M, Pontes JE, Pierce JM Jr. Urological injuries associated with pelvic trauma. J Urol 1979; 121:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/21\">",
"      Avey G, Blackmore CC, Wessells H, et al. Radiographic and clinical predictors of bladder rupture in blunt trauma patients with pelvic fracture. Acad Radiol 2006; 13:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/22\">",
"      Morey AF, Iverson AJ, Swan A, et al. Bladder rupture after blunt trauma: guidelines for diagnostic imaging. J Trauma 2001; 51:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/23\">",
"      Morgan DE, Nallamala LK, Kenney PJ, et al. CT cystography: radiographic and clinical predictors of bladder rupture. AJR Am J Roentgenol 2000; 174:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/24\">",
"      Elliott SP, McAninch JW. Ureteral injuries from external violence: the 25-year experience at San Francisco General Hospital. J Urol 2003; 170:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/25\">",
"      Shlamovitz GZ, Mower WR, Bergman J, et al. Poor test characteristics for the digital rectal examination in trauma patients. Ann Emerg Med 2007; 50:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/26\">",
"      Esposito TJ, Ingraham A, Luchette FA, et al. Reasons to omit digital rectal exam in trauma patients: no fingers, no rectum, no useful additional information. J Trauma 2005; 59:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/27\">",
"      Ball CG, Jafri SM, Kirkpatrick AW, et al. Traumatic urethral injuries: does the digital rectal examination really help us? Injury 2009; 40:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/28\">",
"      Shlamovitz GZ, McCullough L. Blind urethral catheterization in trauma patients suffering from lower urinary tract injuries. J Trauma 2007; 62:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/29\">",
"      Spencer Netto FA, Hamilton P, Kodama R, et al. Retrograde urethrocystography impairs computed tomography diagnosis of pelvic arterial hemorrhage in the presence of a lower urologic tract injury. J Am Coll Surg 2008; 206:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/30\">",
"      Mee SL, McAninch JW, Robinson AL, et al. Radiographic assessment of renal trauma: a 10-year prospective study of patient selection. J Urol 1989; 141:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/31\">",
"      Haas CA, Brown SL, Spirnak JP. Limitations of routine spiral computerized tomography in the evaluation of bladder trauma. J Urol 1999; 162:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/32\">",
"      Hsieh CH, Chen RJ, Fang JF, et al. Diagnosis and management of bladder injury by trauma surgeons. Am J Surg 2002; 184:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/33\">",
"      Morey AF, McAninch JW, Tiller BK, et al. Single shot intraoperative excretory urography for the immediate evaluation of renal trauma. J Urol 1999; 161:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/34\">",
"      Bandi G, Santucci RA. Controversies in the management of male external genitourinary trauma. J Trauma 2004; 56:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/35\">",
"      Jones AE, Mason PE, Tayal VS, Gibbs MA. Sonographic intraperitoneal fluid in patients with pelvic fracture: two cases of traumatic intraperitoneal bladder rupture. J Emerg Med 2003; 25:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/36\">",
"      Fraser JD, Aguayo P, Ostlie DJ, St Peter SD. Review of the evidence on the management of blunt renal trauma in pediatric patients. Pediatr Surg Int 2009; 25:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/37\">",
"      Santucci RA, Langenburg SE, Zachareas MJ. Traumatic hematuria in children can be evaluated as in adults. J Urol 2004; 171:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/38\">",
"      Santucci RA, McAninch JW, Safir M, et al. Validation of the American Association for the Surgery of Trauma organ injury severity scale for the kidney. J Trauma 2001; 50:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18425/abstract/39\">",
"      Sangthong B, Demetriades D, Martin M, et al. Management and hospital outcomes of blunt renal artery injuries: analysis of 517 patients from the National Trauma Data Bank. J Am Coll Surg 2006; 203:612.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 354 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-197.136.42.3-BC92F1AF1C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18425=[""].join("\n");
var outline_f17_63_18425=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY, PHYSIOLOGY, AND MECHANISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREHOSPITAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PRIMARY EVALUATION AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Initial assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      History, examination, and approach to testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Plain x-rays",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Retrograde urethrogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Retrograde cystogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - CT scanning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Intravenous pyelography (IVP)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Retrograde pyelography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PEDIATRIC CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUBSEQUENT MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      PITFALLS OF MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      DEFINITIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2654007\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/354\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/354|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/5/44112\" title=\"diagnostic image 1\">",
"      Open book pelvic fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/40/25217\" title=\"diagnostic image 2\">",
"      Cystogram bladder rupture extraperitoneal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/12/18630\" title=\"diagnostic image 3\">",
"      CT cystogram bladder rupture intraperitoneal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/58/42914\" title=\"diagnostic image 4\">",
"      CT cystogram bladder rupture extraperitoneal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/9/34963\" title=\"diagnostic image 5\">",
"      CT cystogram bladder rupture coronal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?7/61/8148\" title=\"diagnostic image 6\">",
"      CT Grade V renal injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/24/9605\" title=\"diagnostic image 7\">",
"      Renal injury delay CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/354|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/6/2152\" title=\"figure 1\">",
"      Urinary system location anterior view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/40/11913\" title=\"figure 2\">",
"      Urinary system location anterolateral view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/36/10825\" title=\"figure 3\">",
"      Urinary system anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/22/42345\" title=\"figure 4\">",
"      Hemisected male pelvis and perineum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/1/32786\" title=\"figure 5\">",
"      Scrotal anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/23/26995\" title=\"figure 6\">",
"      Anatomy female genitalia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/12/10441\" title=\"figure 7\">",
"      Cross section of female pelvis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/5/29784\" title=\"figure 8\">",
"      Kidney injury grades",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/354|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/32/44546\" title=\"picture 1\">",
"      Anatomy male genitalia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/354|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/53/8028\" title=\"table 1\">",
"      AAST kidney injury scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/2/44071?source=related_link\">",
"      Evaluation and management of lower genital tract trauma in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=related_link\">",
"      Evaluation of sexual abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/5/19545?source=related_link\">",
"      Initial evaluation and management of blunt abdominal trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/11/35002?source=related_link\">",
"      Initial management of trauma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/25/30100?source=related_link\">",
"      Management of zipper injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/7/22650?source=related_link\">",
"      Pelvic trauma: Initial evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/47/40697?source=related_link\">",
"      Placement and management of urinary bladder catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/4/17482?source=related_link\">",
"      Prehospital care of the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/53/35669?source=related_link\">",
"      Straddle injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_63_18426="Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment";
var content_f17_63_18426=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18426/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18426/contributors\">",
"     Craig A Elmets, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18426/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18426/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18426/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?17/63/18426/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?17/63/18426/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?17/63/18426/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 4, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photosensitivity disorders of the skin are conditions in which an abnormal cutaneous response occurs after exposure to ultraviolet radiation or visible light. The major categories of photosensitivity disorders are idiopathic photodermatoses, photodermatoses due to exogenous or endogenous agents, photoexacerbated dermatoses, and photosensitive genodermatoses, and will be reviewed here (",
"    <a class=\"graphic graphic_table graphicRef57800 \" href=\"UTD.htm?15/1/15390\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    An overview of photosensitivity, including photobiology, patient evaluation, and photoprotection, is discussed separately. Polymorphous light eruption, which is a type of idiopathic photodermatosis, is also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/62/20455?source=see_link\">",
"     \"Polymorphous light eruption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     THE IDIOPATHIC PHOTODERMATOSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The idiopathic photodermatoses are a group of photosensitivity disorders whose pathogenesis remains unclear. Many of these disorders have features suggesting that they are immunologically mediated.",
"   </p>",
"   <p>",
"    The idiopathic photodermatoses include polymorphous light eruption, actinic prurigo, hydroa vacciniforme, chronic actinic dermatitis, and solar urticaria (",
"    <a class=\"graphic graphic_table graphicRef57800 \" href=\"UTD.htm?15/1/15390\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Polymorphous light eruption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polymorphous light eruption (PMLE) is the most common idiopathic photodermatosis and is sometimes colloquially called \"sun poisoning\" or &ldquo;sun allergy.&rdquo; PMLE and juvenile spring eruption, a PMLE variant, are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/62/20455?source=see_link\">",
"     \"Polymorphous light eruption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Actinic prurigo",
"    </span>",
"    &nbsp;&mdash;&nbsp;Actinic prurigo, also known as Hutchinson's summer prurigo, familial or hereditary PMLE of American Indians, or hydroa aestivale, is a photo-induced pruritic eruption often considered a variant of PMLE. Actinic prurigo and PMLE may share a common pathophysiologic basis, although actinic prurigo has distinct clinical features [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Onset of actinic prurigo usually occurs in childhood, although it can also first present in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. Patients with childhood onset may spontaneously improve in adolescence, but the condition can persist into adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Actinic prurigo is more common in females [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/1,2\">",
"     1,2",
"    </a>",
"    ], although studies from Singapore and Thailand note a greater number of male patients in the adult-onset cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Actinic prurigo is most commonly seen in Mestizos (ie, individuals of mixed American Indian and European ancestry), although other ethnicities may be affected as well. A family history of actinic prurigo is present in up to 50 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lesions of actinic prurigo are induced by exposure to ultraviolet (UV) radiation. Both UVA and UVB have been implicated; UVA wavelengths elicit the disease in most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Phototesting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Genetic susceptibility is important. Actinic prurigo is associated with an HLA-DR4 polymorphism [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/1,8\">",
"     1,8",
"    </a>",
"    ]. The specific locus HLA-DRB1*0407 has been identified in 60 to 70 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of actinic prurigo usually occurs in the spring, when more time is spent outdoors and more skin is exposed. The lesions can persist through the summer and, unlike PMLE, may even extend into the winter months.",
"   </p>",
"   <p>",
"    Pruritus is characteristic and significant. Commonly, lesions are symmetrically distributed on sun-exposed skin, but covered sites such as the back and buttocks may also be affected [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/7\">",
"     7",
"    </a>",
"    ]. Typical lesions are papulonodular and often have a hemorrhagic crust (",
"    <a class=\"graphic graphic_picture graphicRef81392 \" href=\"UTD.htm?30/0/30735\">",
"     picture 1",
"    </a>",
"    ). Eczematous changes and lichenification are also seen. Occasionally, mild scarring may be present.",
"   </p>",
"   <p>",
"    Actinic cheilitis is a distinguishing feature of the disease and can be seen with other cutaneous findings or as the sole clinical manifestation. Ocular involvement, which manifests as conjunctivitis or pseudopterygium, can occur, although it is rare in Caucasian patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of actinic prurigo is often based upon clinical findings. The differential diagnosis includes prurigo nodularis, arthropod bites, and excoriated eczema.",
"   </p>",
"   <p>",
"    Biopsy findings are not diagnostic but may help to exclude other diseases. Histopathologic features in early lesions include epidermal spongiosis and a superficial and deep perivascular mononuclear infiltrate. More advanced lesions may also exhibit lichenification, focal papillary dermal fibrosis, and irregular epithelial hyperplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/11\">",
"     11",
"    </a>",
"    ]. Biopsies of cheilitis in actinic prurigo reveal characteristic dense lymphocytic infiltrates with distinctive well-formed lymphoid follicles [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Phototesting can be helpful. A case series of 21 patients with actinic prurigo reported reduced minimal erythema doses (MEDs) in 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/2\">",
"     2",
"    </a>",
"    ]. Photoprovocation testing is positive in 60 to 70 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Phototesting'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The implementation of sun protective practices is important for the management of actinic prurigo. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Photoprotection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Topical corticosteroids can offer additional relief for some patients; in a case series of eight patients with actinic prurigo, intermittent 3 to 14 day courses of topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"     clobetasol",
"    </a>",
"    led to marked improvement in seven patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/12\">",
"     12",
"    </a>",
"    ]. Oral glucocorticoids can temporarily improve symptoms during acute exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Phototherapy with narrow band UVB [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/13\">",
"     13",
"    </a>",
"    ] or PUVA [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/14\">",
"     14",
"    </a>",
"    ] is a therapeutic option in patients with persistent symptoms. In most situations, a short course of oral corticosteroids is administered at the beginning of phototherapy to prevent a flare of disease. Treatment is initiated in the spring, prior to seasonal recurrence, since the disorder typically worsens during the summer months. In a case series of five patients treated with PUVA twice weekly for 15 weeks, all patients reported increased tolerance to sun exposure after four weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/14\">",
"     14",
"    </a>",
"    ]. By the end of therapy, measurements of MEDs approximated those of normal skin, and the subjects were able to tolerate summer sun exposure without the recurrence of symptoms.",
"   </p>",
"   <p>",
"    In a separate case series, six patients with actinic prurigo treated prophylactically with ten narrowband UVB treatment sessions delivered over two to five weeks exhibited improved tolerance to sun exposure after completing therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/13\">",
"     13",
"    </a>",
"    ]. During the treatment cycle, pruritus developed in five patients. Pruritus was associated with induction of actinic prurigo in four patients.",
"   </p>",
"   <p>",
"    Phototherapy is not curative, and symptoms of actinic prurigo eventually recur after treatment is discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29673?source=see_link\">",
"     Thalidomide",
"    </a>",
"    has been successful in patients with resistant disease in case series and case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/2,15-19\">",
"     2,15-19",
"    </a>",
"    ]. In one case series, 32 out of 34 patients with actinic prurigo improved with thalidomide [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/15\">",
"     15",
"    </a>",
"    ]. The potential for side effects such as peripheral neuropathy and teratogenicity must be carefully considered prior to initiating thalidomide therapy.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29673?source=see_link\">",
"     Thalidomide",
"    </a>",
"    is prescribed at a dose of 50 to 100",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    and is subsequently tapered to the lowest dose that sustains improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/20\">",
"     20",
"    </a>",
"    ]. Maintenance doses as low as 50",
"    <span class=\"nowrap\">",
"     mg/week",
"    </span>",
"    have been used, and cases in which patients have been able to discontinue treatment without recurrence have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hydroa vacciniforme",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydroa vacciniforme is a rare photodermatosis of childhood, characterized by vesicular lesions on sun-exposed skin that eventually heal, leaving depressed scars.",
"   </p>",
"   <p>",
"    The prevalence of hydroa vacciniforme has been estimated to be 0.34 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/21\">",
"     21",
"    </a>",
"    ]. The disease onset typically occurs in childhood, with a mean duration of nine years from symptom onset to resolution [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/21\">",
"     21",
"    </a>",
"    ]. Resolution usually occurs by adolescence or young adulthood, although symptoms may persist throughout life in some patients. Males have been noted to have a more severe disease, with later onset and longer course than in females [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/21\">",
"     21",
"    </a>",
"    ]. Hydroa aestivale, a milder form of hydroa vacciniforme, is more frequent in females.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of hydroa vacciniforme is unclear. Photoprovocation testing with UVA produces skin findings that resemble lesions induced by natural sunlight in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are multiple reports of atypical hydroa vacciniforme or hydroa vacciniforme-like eruption associated with chronic or latent EBV infection and lymphoproliferative disorders in children and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/22-28\">",
"     22-28",
"    </a>",
"    ]. These patients may have associated symptoms of lymphadenopathy, hepatosplenomegaly, fever, and fatigue that are not seen with typical hydroa vacciniforme. Skin lesions are more severe in these patients. Evaluation for a lymphoproliferative disorder should be based upon clinical presentation and suspicion.",
"   </p>",
"   <p>",
"    The presence of latent EBV in typical hydroa vacciniforme in the absence of systemic symptoms or lymphoproliferative disease has also been reported and may be a contributing factor in the etiology [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Biopsy specimens taken from lesions provoked by repeated exposure to UVA radiation have significantly more EBV positive cells than adjacent normal skin and, on electron microscopy, viral particles can be found in keratinocytes from lesional skin, but not in normal skin. Moreover, greater amounts of EBV DNA have been found in blood samples from individuals with hydroa vacciniforme compared to individuals with other photosensitivity disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Clinical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydroa vacciniforme occurs primarily in the summer. Sunlight induces the lesions on exposed areas of skin, most commonly the face and dorsal hands, within hours of sun exposure. The eruption is symmetric, exhibiting erythematous macules that progress to tender papules, vesicles, and crusts (",
"    <a class=\"graphic graphic_picture graphicRef54500 graphicRef68305 \" href=\"UTD.htm?13/44/14024\">",
"     picture 2A-B",
"    </a>",
"    ). Lesions are associated with pruritus or a burning sensation. Unlike PMLE, hydroa vacciniforme heals with scarring. In rare cases, patients may also experience malaise, fever, or headaches during flares.",
"   </p>",
"   <p>",
"    Rarely, ocular findings may be present, such as photophobia, lacrimation, conjunctivitis, corneal infiltration with vascularization, keratitis, or uveitis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. Referral to an ophthalmologist is recommended if eye symptoms are present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of hydroa vacciniforme is clinical, based upon the morphology of the lesions (",
"    <a class=\"graphic graphic_picture graphicRef54500 graphicRef68305 \" href=\"UTD.htm?13/44/14024\">",
"     picture 2A-B",
"    </a>",
"    ). Photoprovocation tests may be performed to establish the diagnosis in equivocal cases. Skin biopsy may be helpful but requires correlation with clinical findings. Histopathologic examination of active lesions reveals intracellular and intercellular edema, reticular degeneration, vesiculation, and epidermal necrosis. Dermal findings include a perivascular lymphohistiocytic and neutrophilic infiltrate [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/11\">",
"     11",
"    </a>",
"    ]. Photoprovocation tests may be performed to establish the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Phototesting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis includes erythropoietic protoporphyria (EPP) and bullous lupus erythematosus. Porphyrin studies are helpful in excluding EPP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15834?source=see_link\">",
"     \"Erythropoietic protoporphyria\"",
"    </a>",
"    .) Hydroa vacciniforme and bullous lupus erythematosus can be distinguished histologically. In addition, anti-nuclear antibodies and biopsy specimens for direct immunofluorescence are usually positive in lupus but negative in hydroa vacciniforme.",
"   </p>",
"   <p>",
"    The role of serology for EBV in differentiating hydroa vacciniforme from other photosensitivity disorders has not been systematically evaluated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydroa vacciniforme is difficult to treat. All patients should be encouraged to engage in strict photoprotection via avoidance of sun exposure and the use of broad-spectrum sunscreens and sun protective clothing. Individuals with severe disease may need to apply films that block wavelengths within the UV spectrum to automobile and house windows. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Photoprotection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Controlled therapeutic trials have not been performed in hydroa vacciniforme. In a case series of five patients, three were found to respond to photodesensitization with narrowband UVB [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/21\">",
"     21",
"    </a>",
"    ]. Other treatments include antimalarials, intermittent corticosteroids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , and dietary fish oil [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/33-36\">",
"     33-36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12594781\">",
"    <span class=\"h2\">",
"     Chronic actinic dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic actinic dermatitis (CAD) is a rare, persistent photo-induced eczema affecting the exposed skin. Elderly men with a history of significant occupational or recreational sun exposure are most commonly affected, although it is becoming more frequent in younger patients and in women [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Both light and dark-skinned individuals can develop chronic actinic dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/38-40\">",
"     38-40",
"    </a>",
"    ]. Many patients have a coexisting allergic contact dermatitis, frequently to airborne allergens, but also to carba mix and paraphenylenediamine. Photocontact allergies are also frequent. In the past, these were primarily plant photoallergens. Currently, the most common photoallergens associated with chronic actinic dermatitis are agents found in sunscreens, especially avobenzone (Parsol 1789) and oxybenzone. Among the plant photoallergens, Tanacetum vulgare (common tansy) and Taraxacum officinale (common dandelion) predominate [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/37,38,41,42\">",
"     37,38,41,42",
"    </a>",
"    ]. An association with atopic dermatitis may also exist [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/40,43-45\">",
"     40,43-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic actinic dermatitis begins in most cases with an abnormal sensitivity to UVB or, uncommonly, to UVA. With time, signs and symptoms can be elicited by a wider spectrum of wavelengths, sometimes extending into the visible spectrum.",
"   </p>",
"   <p>",
"    The pathogenesis of CAD is not completely understood. One theory is that CAD is a delayed type hypersensitivity reaction against a photo-induced endogenous antigen. An alternative hypothesis is that CAD represents the response to an exogenous photosensitizer, which persists for a prolonged period of time in the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/46,47\">",
"     46,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic actinic dermatitis presents with eczematous patches distributed on the face, neck, dorsal hands, scalp, and upper chest, often with sharp demarcations at lines of clothing. Lichenification and erythematous, infiltrated papules and plaques may also be seen (",
"    <a class=\"graphic graphic_picture graphicRef78558 \" href=\"UTD.htm?29/54/30562\">",
"     picture 3",
"    </a>",
"    ). Although initially present exclusively on sun-exposed skin, the disease can progress over the years to unexposed areas as well. In severe cases, generalized erythroderma may develop [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/48\">",
"     48",
"    </a>",
"    ]. Palmar and plantar eczema are not uncommon. Patients may have abnormal cutaneous findings year-round, but the eruption typically worsens in the summertime.",
"   </p>",
"   <p>",
"    Three different clinical pictures, formerly considered distinct entities, are recognized: actinic reticuloid, photosensitive eczema and persistent light reactivity. Transition from one form to another can occur.",
"   </p>",
"   <p>",
"    Symptoms of CAD often persist for years; approximately 20 percent of patients go into remission within 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <strong>",
"     Diagnosis",
"    </strong>",
"    &mdash; The diagnosis of CAD is based upon the clinical finding of a persistent eczematous eruption affecting primarily the sun-exposed skin in older individuals and the documentation of increased sensitivity (decreased MED) to UVB, often to UVA, and occasionally to visible light by phototesting [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/37,38,43\">",
"     37,38,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patch testing and photopatch testing are also useful for diagnosis. Patch tests and photopatch tests are used to identify coexisting contact allergens",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    photoallergens that may exacerbate the disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/40,49\">",
"     40,49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Diagnostic studies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Skin biopsy may be helpful for diagnosis. Histopathologic findings include epidermal spongiosis, lymphocyte exocytosis, and a superficial and deep perivascular, lymphohistiocytic infiltrate. Lymphocyte exocytosis and small collections of atypical mononuclear cells in the epidermis, resembling the Pautrier microabscesses of mycosis fungoides, may also be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Phototesting is helpful to distinguish CAD from cutaneous lymphoma since photosensitivity is not a usual feature of CTCL, although occasionally CTCL can exhibit increased photosensitivity [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/20,49\">",
"     20,49",
"    </a>",
"    ]. Circulating S&eacute;zary cells can be found either in CAD or in CTCL [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Overlapping clinical and histologic findings make it difficult to differentiate chronic actinic dermatitis from photoaggravated atopic or seborrheic dermatitis, contact dermatitis, PMLE, and systemic drug-induced photosensitivity, although age of onset and certain historical features (eg, drug exposure) may be helpful in some cases. Rarely, the two disorders may coexist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is often difficult. Strict sun protection should be emphasized but often is ineffective as a sole measure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Photoprotection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Avoidance of known contact and photocontact allergens as well as photosensitizing drugs is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/43\">",
"     43",
"    </a>",
"    ]. Broad-spectrum sunscreens should be used only after patch and photopatch tests rule out a sunscreen allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/50\">",
"     50",
"    </a>",
"    ]. Although no randomized trials have evaluated these therapies, topical corticosteroids, topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/51-54\">",
"     51-54",
"    </a>",
"    ],",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emollients may help.",
"   </p>",
"   <p>",
"    For more severe cases, systemic therapy may be prescribed.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     Azathioprine",
"    </a>",
"    was effective in one small randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/55\">",
"     55",
"    </a>",
"    ];",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/56\">",
"     56",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/57\">",
"     57",
"    </a>",
"    ] have led to improvement in anecdotal reports. Low-dose PUVA or narrowband UVB, initially given with oral glucocorticoids to decrease treatment-induced flares, has been effective in small case series [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/58-60\">",
"     58-60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Solar urticaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Solar urticaria is a rare variant of urticaria. Pruritic, erythematous wheals appear within 5 to 10 minutes of sun exposure and resolve within 24 hours (",
"    <a class=\"graphic graphic_picture graphicRef57783 \" href=\"UTD.htm?33/13/34003\">",
"     picture 4",
"    </a>",
"    ). Symptoms can be induced via exposure to UVA, UVB, or visible light; the precise wavelengths vary from individual to individual.",
"   </p>",
"   <p>",
"    Phototesting is useful to confirm the diagnosis and typically results in the appearance of urticaria within minutes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Phototesting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pharmacologic therapy or photodesensitization with low-dose PUVA or narrowband UVB initially given with oral glucocorticoids is usually required for management [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A detailed review of the clinical manifestations, diagnosis, and treatment of solar urticaria is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24666?source=see_link&amp;anchor=H36#H36\">",
"     \"Physical urticarias\", section on 'Solar urticaria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     PHOTOSENSITIVITY DUE TO EXOGENOUS AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photosensitivity induced by exogenous agents refers to a process in which chemicals or drugs that are ingested or applied to the skin promote a photosensitivity reaction when the individual is exposed to sunlight. This type of photosensitivity is usually divided into phototoxic and photoallergic reactions; phytophotodermatitis is a special form of toxicity elicited by photosensitizing chemicals in plants. Phototoxic and photoallergic reactions differ in their clinical features and causative agents (",
"    <a class=\"graphic graphic_table graphicRef50323 \" href=\"UTD.htm?14/39/14972\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Phototoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phototoxicity results from direct tissue or cellular damage following ultraviolet irradiation of a phototoxic agent that has been ingested or applied to the skin. Phototoxicity can occur in any individual in whom the threshold concentration of the chemical or drug has been reached [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. By contrast, photoallergy is a cell-mediated immune response elicited by small amounts of compound in previously sensitized individuals (",
"    <a class=\"graphic graphic_table graphicRef50323 \" href=\"UTD.htm?14/39/14972\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The majority of drug-induced photosensitivity reactions are phototoxic. Common offenders include [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tetracyclines (especially",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Thiazides",
"     </li>",
"     <li>",
"      Sulfonamides",
"     </li>",
"     <li>",
"      Fluoroquinolones",
"     </li>",
"     <li>",
"      NSAIDS (especially",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/25/9625?source=see_link\">",
"       piroxicam",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/36/43592?source=see_link\">",
"       ketoprofen",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Phenothiazines (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/38/30312?source=see_link\">",
"       chlorpromazine",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Psoralens",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/61/6102?source=see_link\">",
"       Griseofulvin",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"       Voriconazole",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/22/3428?source=see_link\">",
"       Aminolevulinic acid",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/7/35955?source=see_link\">",
"       methyl aminolevulinate",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39157?source=see_link\">",
"       Porfimer",
"      </a>",
"      sodium",
"     </li>",
"     <li>",
"      Retinoids",
"     </li>",
"     <li>",
"      Tar compounds",
"     </li>",
"     <li>",
"      St. John&rsquo;s wort",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Phototoxic reactions appear as an exaggerated sunburn (",
"    <a class=\"graphic graphic_picture graphicRef76399 graphicRef69140 graphicRef86479 \" href=\"UTD.htm?31/30/32234\">",
"     picture 5A-C",
"    </a>",
"    ). The reaction usually evolves within minutes to hours of sun exposure and is restricted to exposed skin [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/62\">",
"     62",
"    </a>",
"    ]. In severe cases, vesicles or bullae may be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/46\">",
"     46",
"    </a>",
"    ]. Skin biopsy findings are identical to those of ordinary sunburn, with vacuolated and apoptotic keratinocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most phototoxic drugs are activated by UVA rather than UVB radiation.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/22/3428?source=see_link\">",
"     Aminolevulinic acid",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/7/35955?source=see_link\">",
"     methyl aminolevulinate",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39157?source=see_link\">",
"     porfimer",
"    </a>",
"    sodium are activated by wavelengths in the visible spectrum. A special form of phototoxicity occurs following contact with tar compounds. Tar phototoxicity occurs primarily in road workers and roofers who employ tar in their occupations. Occasionally it can be seen in individuals who use tar containing shampoos. A burning and stinging pain, called &ldquo;tar smarts&rdquo;, occurs within minutes of exposure to sunlight. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Phytophotodermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical exposure to plant-derived substances may also cause a phototoxic reaction termed phytophotodermatitis.",
"   </p>",
"   <p>",
"    The most common plants that cause phytophotodermatitis are in the Apiaceae (ie, Umbelliferae) and Rutaceae families [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/64\">",
"     64",
"    </a>",
"    ]. Commonly encountered members include celery, wild parsnip, and parsley (Apiaceae), as well as lemons and limes (Rutaceae). The sap of fig trees (Ficus carica) and seeds of Psoralea corylifolia are additional inducers of phytophotodermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A list of plants that may cause phytophotodermatitis is provided (",
"    <a class=\"graphic graphic_table graphicRef75581 \" href=\"UTD.htm?1/63/2044\">",
"     table 3",
"    </a>",
"    ). All of these plants contain furocoumarins, of which psoralens and angelicins are the most notable examples. The furocoumarins alone are inactive, but, following exposure to UVA radiation, they may induce a photosensitivity reaction. &nbsp;",
"   </p>",
"   <p>",
"    Phytophotodermatitis occurs most commonly after exposure to limes, especially in bartenders and others who squeeze limes when making cocktails and other drinks. Other citrus fruits contain furocoumarins and may infrequently cause a phytophotodermatitis. Phytophotodermatitis is also seen in gardeners, children who come in contact with plants and weeds while playing in fields and meadows, chefs, and food-industry workers, especially those who handle celery. &nbsp;",
"   </p>",
"   <p>",
"    Patients with phytophotodermatitis typically present with erythema, edema, and bullae in linear or bizarre configurations on sun-exposed skin that reflect the manner in which they have come in contact with the plant (",
"    <a class=\"graphic graphic_picture graphicRef77829 graphicRef57871 \" href=\"UTD.htm?33/32/34313\">",
"     picture 6A-B",
"    </a>",
"    ). For example, people who develop phytophotodermatitis from exposure to plants in meadows and fields often have a linear distribution to their cutaneous eruption. The clinical findings appear approximately 24 hours after sun exposure. Lesions are not pruritic, and may be painful. As the acute eruption clears, it is replaced by hyperpigmentation that may take months to years to resolve. It should be noted that often the preceding erythema is inapparent and only the hyperpigmentation is observed. &nbsp;",
"   </p>",
"   <p>",
"    Generalized phototoxic reactions secondary to the ingestion of large quantities of furocoumarins are rare. A few cases of generalized phototoxic reactions have occurred following PUVA therapy or tanning salon use in patients who had consumed large amounts of celery [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]. Hypericin, a non-furocoumarin photosensitizing substance found in St. John's wort (Hypericum perforatum), can also lead to a generalized phototoxic reaction on sun-exposed skin after ingestion of high doses of the plant extract. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/8/27784?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical use of St. John's wort\", section on 'Adverse effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Other manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other manifestations of phototoxicity include pseudoporphyria, usually caused by nonsteroidal antiinflammatory drugs (NSAIDs, most commonly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/43/43705?source=see_link\">",
"     naproxen",
"    </a>",
"    ),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/62,69\">",
"     62,69",
"    </a>",
"    ], photo-onycholysis due to tetracyclines and psoralens, and slate-gray hyperpigmentation due to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/38/30312?source=see_link\">",
"     chlorpromazine",
"    </a>",
"    , tricyclic antidepressants, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/49,61,62\">",
"     49,61,62",
"    </a>",
"    ]. Pseudoporphyria presents with the features of skin fragility and subepidermal blisters typically seen in porphyria cutanea tarda.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Photoallergy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photoallergy is a delayed-type hypersensitivity reaction to an allergen whose antigenicity has changed after exposure to UVR (photoallergen). Once the photoallergen has formed, the subsequent steps in the pathogenesis of the reaction are identical to allergic contact dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/49,61,62\">",
"     49,61,62",
"    </a>",
"    ]. As in other allergic contact dermatitis reactions, affected individuals must have been previously sensitized to the photoallergen. Similar to phototoxic reactions, most photoallergic reactions are initiated by UVA rather than UVB exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Photoallergic reactions are typically pruritic, eczematous eruptions in sun-exposed areas of skin that develop 24 to 48 hours after sun exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/70\">",
"     70",
"    </a>",
"    ]. Occasionally, photoallergic contact dermatitis may become persistent and evolve into chronic actinic dermatitis, even after the offending drug or chemical has been discontinued. (See",
"    <a class=\"local\" href=\"#H12594781\">",
"     'Chronic actinic dermatitis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Photoallergic reactions occur in most instances after exposure to topical rather than systemic agents (",
"    <a class=\"graphic graphic_picture graphicRef63557 \" href=\"UTD.htm?7/46/7907\">",
"     picture 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common topical agents responsible for photoallergic reactions are [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/49,61,70,71\">",
"     49,61,70,71",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sunscreens (eg, benzophenones, cinnamates, dibenzoylmethanes)",
"     </li>",
"     <li>",
"      Antimicrobial agents (eg, bithionol,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/36/12870?source=see_link\">",
"       chlorhexidine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/62/33763?source=see_link\">",
"       hexachlorophene",
"      </a>",
"      , fenticlor)",
"     </li>",
"     <li>",
"      NSAIDs (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/36/43592?source=see_link\">",
"       ketoprofen",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/29/38352?source=see_link\">",
"       diclofenac",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fragrances (eg, 6-methylcoumarin, musk ambrette, sandalwood oil)",
"     </li>",
"     <li>",
"      Phenothiazines (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/20/15688?source=see_link\">",
"       promethazine",
"      </a>",
"      , available in Europe as topical antihistamine)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Systemic medications that can induce photoallergic reactions include [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/49\">",
"     49",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/48/777?source=see_link\">",
"       quinidine",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/61/6102?source=see_link\">",
"       griseofulvin",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/46/15080?source=see_link\">",
"       quinine",
"      </a>",
"     </li>",
"     <li>",
"      quinolones",
"     </li>",
"     <li>",
"      sulfonamides",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/36/43592?source=see_link\">",
"       ketoprofen",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/25/9625?source=see_link\">",
"       piroxicam",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough history regarding photosensitivity and a full skin examination are essential to accurately diagnose phototoxicity or photoallergy. If the diagnosis remains uncertain, phototesting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    photopatch testing are useful. Minimal erythema doses (MEDs) are decreased in patients with phototoxicity or photoallergy secondary to a systemic agent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/72\">",
"     72",
"    </a>",
"    ]. Photopatch testing identifies patients with photoallergic contact dermatitis.",
"   </p>",
"   <p>",
"    In phototoxic reactions, histopathologic findings include ballooning of keratinocytes with scattered apoptotic keratinocytes (sunburn cells), variable spongiosis, and a mild or moderate superficial inflammatory cell infiltrate in the dermis. In severe reactions, epidermal necrosis may be seen.",
"   </p>",
"   <p>",
"    In photoallergic reactions, histopathologic findings are similar to those of allergic contact dermatitis. Spongiosis, mild acanthosis, and a superficial perivascular lymphocytic infiltrate with eosinophils are usually seen [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Diagnostic studies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;For both phototoxic and photoallergic reactions, the offending drug or chemical causing exogenous photosensitivity should be discontinued whenever possible. Sun-protective measures such as sun avoidance, sun-protective clothing, and sunscreen are essential. Photosensitivity due to exogenous agents is often greatest in the long-wave UVA range. Broad spectrum sunscreens which offer adequate UVA protection are indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection\", section on 'Photoprotection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most phototoxic reactions can be treated as sunburn. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30136?source=see_link\">",
"     \"Sunburn\"",
"    </a>",
"    .) Symptomatic treatment with cool compresses, emollients and oral analgesics usually suffice. Topical anesthetics should be avoided because of the possibility of a contact allergy.",
"   </p>",
"   <p>",
"    Photoallergic reactions should be treated in a manner similar to contact allergy. Specifically, application of topical corticosteroids to the involved areas will reduce pruritus and the inflammatory response. In some instances, a two to three week course of systemic corticosteroids may be necessary. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     PHOTOSENSITIVITY DUE TO ENDOGENOUS AGENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Porphyria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several types of porphyria exhibit photosensitivity as a clinical manifestation. Examples include porphyria cutanea tarda, erythropoietic protoporphyria, variegate porphyria, congenital erythropoietic porphyria, hereditary coproporphyria, and hepatoerythropoietic porphyria. Diagnosis and treatment of the porphyrias are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/19/28984?source=see_link\">",
"     \"Porphyrias: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28458?source=see_link\">",
"     \"Porphyria cutanea tarda and hepatoerythropoietic porphyria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15834?source=see_link\">",
"     \"Erythropoietic protoporphyria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/42/5801?source=see_link\">",
"     \"Congenital erythropoietic porphyria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/51/825?source=see_link\">",
"     \"Variegate porphyria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/45/41687?source=see_link\">",
"     \"Hereditary coproporphyria\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Smith-Lemli-Opitz syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smith-Lemli-Opitz syndrome, a rare autosomal recessive disorder associated with severe photosensitivity in more than 50 percent of patients, is a photosensitive disorder that may be due to an endogenous agent [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/73\">",
"     73",
"    </a>",
"    ]. The syndrome is caused by an inborn error of cholesterol metabolism, in which a deficiency of 7-dehydrocholesterol reductase activity leads to increased levels of 7-dehydrocholesterol. The relationship of abnormal cholesterol metabolism to photosensitivity remains unclear. Patients appear to be sensitive to UVA [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical findings, in addition to photosensitivity, include syndactyly, growth failure, craniofacial and cardiac disorders, intellectual and behavioral problems, and multiple other abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     PHOTOEXACERBATED DERMATOSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photoexacerbated dermatoses are disorders that are exacerbated by sun exposure. Two well-known examples are lupus erythematosus and dermatomyositis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Lupus erythematosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous manifestations of lupus erythematosus, which may be initiated or exacerbated by UVR, include acute cutaneous lupus, subacute cutaneous lupus, and discoid lupus.",
"   </p>",
"   <p>",
"    Acute cutaneous lupus is seen in patients with systemic lupus erythematosus (SLE) and classically affects the malar area. Subacute cutaneous lupus may be associated with SLE, but may occur without systemic involvement. Subacute cutaneous lupus is manifested as photo-distributed scaly erythematous psoriasiform papules and plaques, which at times may have an annular appearance.",
"   </p>",
"   <p>",
"    Another lupus subtype, discoid lupus, is sometimes clearly photosensitive. However, the frequent occurrence of discoid lesions on the relatively sun-protected scalp and conchal bowl of the ears is evidence against a strict requirement of sun exposure for discoid lesions to form. However, discoid lupus lesions have been produced experimentally by repeated exposure to ultraviolet radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/75,76\">",
"     75,76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A more comprehensive discussion of cutaneous lupus is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36378?source=see_link\">",
"     \"Mucocutaneous manifestations of systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Drug-induced subacute cutaneous lupus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug-induced subacute cutaneous lupus erythematosus (SCLE) presents with a photosensitive cutaneous eruption identical to idiopathic SCLE [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/77\">",
"     77",
"    </a>",
"    ]. Among the medications reported to induce subacute cutaneous lupus,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/22/33120?source=see_link\">",
"     terbinafine",
"    </a>",
"    , thiazide diuretics, and calcium channel blockers are more frequently involved [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36378?source=see_link&amp;anchor=H7#H7\">",
"     \"Mucocutaneous manifestations of systemic lupus erythematosus\", section on 'Subacute cutaneous lupus erythematosus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Dermatomyositis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cutaneous findings associated with dermatomyositis are often induced by UVR and appear on sun-exposed skin. Classic skin findings include a heliotrope rash on the face, erythematous papules overlying dorsal PIP joints (Gottron's papules), and scaly violaceous erythema in a &ldquo;shawl distribution&rdquo; (ie, a diffuse violaceous erythema over the back and shoulders) and on the \"v\"-area of the chest. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=see_link\">",
"     \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29368?source=see_link\">",
"     \"Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of cases of photoexacerbation exist for a number of other diseases, including [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/49\">",
"     49",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acne",
"     </li>",
"     <li>",
"      Atopic dermatitis",
"     </li>",
"     <li>",
"      Bullous pemphigoid",
"     </li>",
"     <li>",
"      Carcinoid syndrome",
"     </li>",
"     <li>",
"      Cutaneous T-cell lymphoma",
"     </li>",
"     <li>",
"      Disseminated superficial actinic porokeratosis",
"     </li>",
"     <li>",
"      Erythema multiforme",
"     </li>",
"     <li>",
"      Familial benign chronic pemphigus (Hailey-Hailey disease)",
"     </li>",
"     <li>",
"      Hartnup disease",
"     </li>",
"     <li>",
"      HIV infection",
"     </li>",
"     <li>",
"      Keratosis follicularis (Darier disease)",
"     </li>",
"     <li>",
"      Lichen planus",
"     </li>",
"     <li>",
"      Pellagra",
"     </li>",
"     <li>",
"      Pemphigus, including pemphigus foliaceus (erythematosus)",
"     </li>",
"     <li>",
"      Pityriasis rubra pilaris",
"     </li>",
"     <li>",
"      Psoriasis",
"     </li>",
"     <li>",
"      Reticular erythematous mucinosis",
"     </li>",
"     <li>",
"      Rosacea",
"     </li>",
"     <li>",
"      Seborrheic dermatitis",
"     </li>",
"     <li>",
"      Transient acantholytic dermatoses (Grover's disease)",
"     </li>",
"     <li>",
"      Viral infections, including herpes simplex",
"     </li>",
"     <li>",
"      Viral exanthems",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     RARE GENODERMATOSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Photosensitivity is a manifestation of several genodermatoses with DNA repair defects or chromosomal instability. These include xeroderma pigmentosum, Bloom syndrome, Cockayne syndrome, trichothiodystrophy, and Rothmund-Thomson syndrome. Skin cancer, cutaneous poikiloderma, short stature, craniofacial defects, intellectual impairment, or skeletal defects present at an early age may suggest one of these syndromes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/42/35493?source=see_link\">",
"     \"Bloom syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/37/602?source=see_link&amp;anchor=H24#H24\">",
"     \"Hereditary neuropathies associated with generalized disorders\", section on 'DNA repair disorders'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24586?source=see_link&amp;anchor=H523750890#H523750890\">",
"     \"The genodermatoses\", section on 'Disorders with malignant potential'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Kindler syndrome, another photosensitive genodermatosis, is characterized by acral bullae and skin fragility, among other features. The syndrome is caused by a loss-of-function mutation in FERMT-1, which encodes a membrane-associated structural signaling protein [",
"    <a class=\"abstract\" href=\"UTD.htm?17/63/18426/abstract/80\">",
"     80",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28106?source=see_link&amp;anchor=H2900764#H2900764\">",
"     \"Epidemiology, pathogenesis, and clinical features of epidermolysis bullosa\", section on 'Kindler syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Photosensitivity disorders of the skin are conditions in which an abnormal cutaneous response occurs after exposure to ultraviolet radiation or visible light. The major categories of photosensitivity disorders include idiopathic photodermatoses, photodermatoses due to exogenous or endogenous agents, photoexacerbated dermatoses, and photosensitive genodermatoses. A table describing the key features of many of the photosensitive disorders is provided (",
"      <a class=\"graphic graphic_table graphicRef57800 \" href=\"UTD.htm?15/1/15390\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The idiopathic photodermatoses are photosensitive disorders, many of which may be immunologically mediated, although the inciting agents are unknown. Polymorphous light eruption, actinic prurigo, hydroa vacciniforme, chronic actinic dermatitis, and solar urticaria are included in this category. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'The idiopathic photodermatoses'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/62/20455?source=see_link\">",
"       \"Polymorphous light eruption\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Actinic prurigo is a childhood onset pruritic photo-induced eruption most common in Mestizos (ie, individuals of mixed American Indian and European ancestry). Sun protection is an important component of therapy. For all patients with actinic prurigo, we suggest the use of topical corticosteroids as initial therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For patients with moderate to severe disease who do not improve with sun protection and topical corticosteroids, we suggest treatment with prophylactic phototherapy, given initially with a short course of oral corticosteroids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For patients with extensive or resistant disease, we suggest treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/62/29673?source=see_link\">",
"       thalidomide",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Actinic prurigo'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic actinic dermatitis is a persistent photodistributed eczematous eruption often seen in elderly men. Treatment should include sun-protective measures, emollients, and avoidance of inciting agents, if a contact or photocontact allergy is present. We suggest the use of high potency topical corticosteroids",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      as needed for active dermatitis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Refractory cases can benefit from treatment with systemic immunosuppressants or PUVA initially given with oral glucocorticosteroids. (See",
"      <a class=\"local\" href=\"#H12594781\">",
"       'Chronic actinic dermatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Phototoxic reactions resemble an exaggerated sunburn and result from direct tissue or cellular damage following exposure to a phototoxic agent and ultraviolet radiation (UVR). Most drug-induced photosensitivity reactions are phototoxic. Plant furocoumarins and tar also cause phototoxicity. Phototesting is useful for diagnosis. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Phototoxicity'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A photoallergic reaction is a form of allergic contact dermatitis in which a photosensitizing chemical or drug once activated by UVR serves as the allergen and elicits an eczematous reaction in a sensitized individual. Most photoallergic reactions are caused by topical agents, rather than systemic medications. Phototesting and photopatch testing are useful for diagnosis. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Photoallergy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Photosensitive disorders due to endogenous agents include several types of porphyrias. Smith-Lemli-Opitz syndrome may also fit into this category. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Photosensitivity due to endogenous agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Photoexacerbated dermatoses are diseases that are exacerbated by sun exposure, such as lupus erythematosus and dermatomyositis. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Photoexacerbated dermatoses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Photosensitivity is a manifestation of several genodermatoses. Examples include xeroderma pigmentosa, Bloom syndrome, Cockayne syndrome, trichothiodystrophy, Rothmund-Thomson syndrome, and Kindler syndrome. (See",
"      <a class=\"local\" href=\"#H36\">",
"       'Rare genodermatoses'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/1\">",
"      Grabczynska SA, McGregor JM, Kondeatis E, et al. Actinic prurigo and polymorphic light eruption: common pathogenesis and the importance of HLA-DR4/DRB1*0407. Br J Dermatol 1999; 140:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/2\">",
"      Crouch R, Foley P, Baker C. Actinic prurigo: a retrospective analysis of 21 cases referred to an Australian photobiology clinic. Australas J Dermatol 2002; 43:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/3\">",
"      Lane PR, Hogan DJ, Martel MJ, et al. Actinic prurigo: clinical features and prognosis. J Am Acad Dermatol 1992; 26:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/4\">",
"      Akaraphanth R, Sindhavananda J, Gritiyarangsan P. Adult-onset actinic prurigo in Thailand. Photodermatol Photoimmunol Photomed 2007; 23:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/5\">",
"      Lestarini D, Khoo LS, Goh CL. The clinical features and management of actinic prurigo: a retrospective study. Photodermatol Photoimmunol Photomed 1999; 15:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/6\">",
"      McGregor JM, Grabczynska S, Vaughan R, et al. Genetic modeling of abnormal photosensitivity in families with polymorphic light eruption and actinic prurigo. J Invest Dermatol 2000; 115:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/7\">",
"      Ross G, Foley P, Baker C. Actinic prurigo. Photodermatol Photoimmunol Photomed 2008; 24:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/8\">",
"      Vaughan RW, Baker CS, Page G, et al. HLA-DR4 may determine expression of actinic prurigo in British patients. J Invest Dermatol 1996; 106:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/9\">",
"      Ferguson J. Diagnosis and treatment of the common idiopathic photodermatoses. Australas J Dermatol 2003; 44:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/10\">",
"      Hojyo-Tomoka T, Vega-Memije E, Granados J, et al. Actinic prurigo: an update. Int J Dermatol 1995; 34:380.",
"     </a>",
"    </li>",
"    <li>",
"     Hawk JLM, Calonje E. The photosensitivity disorders. In: Lever's Histopathology of the Skin,, 9th ed, Elder DE (Ed), Lippincott Williams and Wilkins, Philadelphia 2005. p.365.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/12\">",
"      Lane PR, Moreland AA, Hogan DJ. Treatment of actinic prurigo with intermittent short-course topical 0.05% clobetasol 17-propionate. A preliminary report. Arch Dermatol 1990; 126:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/13\">",
"      Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995; 132:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/14\">",
"      Farr PM, Diffey BL. Treatment of actinic prurigo with PUVA: mechanism of action. Br J Dermatol 1989; 120:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/15\">",
"      Londo&ntilde;o F. Thalidomide in the treatment of actinic prurigo. Int J Dermatol 1973; 12:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/16\">",
"      Lovell CR, Hawk JL, Calnan CD, Magnus IA. Thalidomide in actinic prurigo. Br J Dermatol 1983; 108:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/17\">",
"      Yong-Gee SA, Muir JB. Long-term thalidomide for actinic prurigo. Australas J Dermatol 2001; 42:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/18\">",
"      Ng JC, Foley PA, Crouch RB, Baker CS. A case of severe actinic prurigo successfully treated with thalidomide. Australas J Dermatol 2001; 42:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/19\">",
"      Estrada-G I, Garibay-Escobar A, N&uacute;&ntilde;ez-V&aacute;zquez A, et al. Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo. Int J Dermatol 2004; 43:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/20\">",
"      Agar N, Morris S, Russell-Jones R, et al. Case report of four patients with erythrodermic cutaneous T-cell lymphoma and severe photosensitivity mimicking chronic actinic dermatitis. Br J Dermatol 2009; 160:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/21\">",
"      Gupta G, Man I, Kemmett D. Hydroa vacciniforme: A clinical and follow-up study of 17 cases. J Am Acad Dermatol 2000; 42:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/22\">",
"      Verneuil L, Gouarin S, Comoz F, et al. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up. Br J Dermatol 2010; 163:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/23\">",
"      Cho KH, Lee SH, Kim CW, et al. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol 2004; 151:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/24\">",
"      Cho KH, Kim CW, Heo DS, et al. Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions. Clin Exp Dermatol 2001; 26:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/25\">",
"      Katagiri Y, Mitsuhashi Y, Kondo S, et al. Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection. J Dermatol 2003; 30:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/26\">",
"      Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol 2002; 147:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/27\">",
"      Wu YH, Chen HC, Hsiao PF, et al. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Int J Dermatol 2007; 46:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/28\">",
"      Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006; 142:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/29\">",
"      Iwatsuki K, Xu Z, Takata M, et al. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 1999; 140:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/30\">",
"      Jeng BH, Margolis TP, Chandra NS, McCalmont TH. Ocular findings as a presenting sign of hydroa vacciniforme. Br J Ophthalmol 2004; 88:1478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/31\">",
"      Bennion SD, Johnson C, Weston WL. Hydroa vacciniforme with inflammatory keratitis and secondary anterior uveitis. Pediatr Dermatol 1987; 4:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/32\">",
"      Wisuthsarewong W, Leenutaphong V, Viravan S. Hydroa vacciniforme with ocular involvement. J Med Assoc Thai 1998; 81:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/33\">",
"      Goldgeier MH, Nordlund JJ, Lucky AW, et al. Hydroa vacciniforme: diagnosis and therapy. Arch Dermatol 1982; 118:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/34\">",
"      Sonnex TS, Hawk JL. Hydroa vacciniforme: a review of ten cases. Br J Dermatol 1988; 118:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/35\">",
"      Rhodes LE, White SI. Dietary fish oil as a photoprotective agent in hydroa vacciniforme. Br J Dermatol 1998; 138:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/36\">",
"      Blackwell V, McGregor JM, Hawk JL. Hydroa vacciniforme presenting in an adult successfully treated with cyclosporin A. Clin Exp Dermatol 1998; 23:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/37\">",
"      Dawe RS, Crombie IK, Ferguson J. The natural history of chronic actinic dermatitis. Arch Dermatol 2000; 136:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/38\">",
"      Que SK, Brauer JA, Soter NA, Cohen DE. Chronic actinic dermatitis: an analysis at a single institution over 25 years. Dermatitis 2011; 22:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/39\">",
"      Kingston TP, Lowe NJ, Sofen HL, Weingarten DP. Actinic reticuloid in a black man: successful therapy with azathioprine. J Am Acad Dermatol 1987; 16:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/40\">",
"      Russell SC, Dawe RS, Collins P, et al. The photosensitivity dermatitis and actinic reticuloid syndrome (chronic actinic dermatitis) occurring in seven young atopic dermatitis patients. Br J Dermatol 1998; 138:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/41\">",
"      Frain-Bell W, Johnson BE. Contact allergic sensitivity to plants and the photosensitivity dermatitis and actinic reticuloid syndrome. Br J Dermatol 1979; 101:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/42\">",
"      Menag&eacute; H, Ross JS, Norris PG, et al. Contact and photocontact sensitization in chronic actinic dermatitis: sesquiterpene lactone mix is an important allergen. Br J Dermatol 1995; 132:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/43\">",
"      Dawe RS, Ferguson J. Diagnosis and treatment of chronic actinic dermatitis. Dermatol Ther 2003; 16:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/44\">",
"      Kurumaji Y, Kondo S, Fukuro S, et al. Chronic actinic dermatitis in a young patient with atopic dermatitis. J Am Acad Dermatol 1994; 31:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/45\">",
"      Creamer D, McGregor JM, Hawk JL. Chronic actinic dermatitis occurring in young patients with atopic dermatitis. Br J Dermatol 1998; 139:1112.",
"     </a>",
"    </li>",
"    <li>",
"     Lim HW. Abnormal responses to ultraviolet radiation: photosensitivity induced by exogenous agents. In: Fitzpatrick's Dermatology in General Medicine, 7th, Wolff K, Goldsmith LA, Katz SI, et al. (Eds), McGraw-Hill, New York 2008. Vol 1, p.828.",
"    </li>",
"    <li>",
"     Hawk JLM, Lim HW. Chronic actinic dermatitis. In: Photodermatology, Lim HW, Honigsmann H, Hawk JLM.  (Eds), Informa Healthcare, New York 2007. p.169.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/48\">",
"      Chu AC, Robinson D, Hawk JL, et al. Immunologic differentiation of the S&eacute;zary syndrome due to cutaneous T-cell lymphoma and chronic actinic dermatitis. J Invest Dermatol 1986; 86:134.",
"     </a>",
"    </li>",
"    <li>",
"     Lim HW, Hawk JLM. Photodermatoses. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Elsevier Limited, 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/50\">",
"      Deleo V. Sunscreen use in photodermatoses. Dermatol Clin 2006; 24:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/51\">",
"      Evans AV, Palmer RA, Hawk JL. Erythrodermic chronic actinic dermatitis responding only to topical tacrolimus. Photodermatol Photoimmunol Photomed 2004; 20:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/52\">",
"      Ogawa Y, Adachi A, Tomita Y. The successful use of topical tacrolimus treatment for a chronic actinic dermatitis patient with complications of idiopathic leukopenia. J Dermatol 2003; 30:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/53\">",
"      Uetsu N, Okamoto H, Fujii K, et al. Treatment of chronic actinic dermatitis with tacrolimus ointment. J Am Acad Dermatol 2002; 47:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/54\">",
"      Busaracome P, Wattanakrai P, Rajatanavin N. Chronic actinic dermatitis with leonine facies and iatrogenic adrenal insufficiency successfully treated with topical tacrolimus. Case Rep Dermatol 2011; 3:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/55\">",
"      Murphy GM, Maurice PD, Norris PG, et al. Azathioprine treatment in chronic actinic dermatitis: a double-blind controlled trial with monitoring of exposure to ultraviolet radiation. Br J Dermatol 1989; 121:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/56\">",
"      Stinco G, Codutti R, Frattasio A, et al. Chronic actinic dermatitis treated with cyclosporine-A. Eur J Dermatol 2002; 12:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/57\">",
"      Thomson MA, Stewart DG, Lewis HM. Chronic actinic dermatitis treated with mycophenolate mofetil. Br J Dermatol 2005; 152:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/58\">",
"      Hindson C, Spiro J, Downey A. PUVA therapy of chronic actinic dermatitis. Br J Dermatol 1985; 113:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/59\">",
"      Sinclair SE, Hindson C. PUVA therapy of chronic actinic dermatitis. Australas J Dermatol 1988; 29:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/60\">",
"      Gambichler T, Breuckmann F, Boms S, et al. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol 2005; 52:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/61\">",
"      Gould JW, Mercurio MG, Elmets CA. Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 1995; 33:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/62\">",
"      Gonz&aacute;lez E, Gonz&aacute;lez S. Drug photosensitivity, idiopathic photodermatoses, and sunscreens. J Am Acad Dermatol 1996; 35:871.",
"     </a>",
"    </li>",
"    <li>",
"     Photosensitivity diseases: principles of diagnosis and treatment, Harber LC, Bickers DR (Eds), BC Decker, Toronto 1989. p.18.",
"    </li>",
"    <li>",
"     McGovern TW. Dermatoses due to plants. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Elsevier Limited, 2008. p.243.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/65\">",
"      Derraik JG, Rademaker M. Phytophotodermatitis caused by contact with a fig tree (Ficus carica). N Z Med J 2007; 120:U2720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/66\">",
"      Boffa MJ, Gilmour E, Ead RD. Celery soup causing severe phototoxicity during PUVA therapy. Br J Dermatol 1996; 135:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/67\">",
"      Puig L, de Moragas JM. Enhancement of PUVA phototoxic effects following celery ingestion: cool broth also can burn. Arch Dermatol 1994; 130:809.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/68\">",
"      Ljunggren B. Severe phototoxic burn following celery ingestion. Arch Dermatol 1990; 126:1334.",
"     </a>",
"    </li>",
"    <li>",
"     Frank J, Poblete-Guti&eacute;rrez P. Porphyria. In: Dermatology, 2nd ed, Bolognia JL, Jorizzo JL, Rapini RP (Eds), Elsevier Limited, 2008.",
"    </li>",
"    <li>",
"     Lim HW. Abnormal responses to ultraviolet radiation: photosensitivity induced by exogenous agents. In: Fitzpatrick's Dermatology in General Medicine, Wolff K, Goldsmith LA, Katz SI, et al (Eds), McGraw-Hill, New York 2008. p.828.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/71\">",
"      Victor FC, Cohen DE, Soter NA. A 20-year analysis of previous and emerging allergens that elicit photoallergic contact dermatitis. J Am Acad Dermatol 2010; 62:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/72\">",
"      Yashar SS, Lim HW. Classification and evaluation of photodermatoses. Dermatol Ther 2003; 16:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/73\">",
"      Anstey A. School in photodermatology: Smith-Lemli-Opitz syndrome. Photodermatol Photoimmunol Photomed 2006; 22:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/74\">",
"      Anstey AV, Ryan A, Rhodes LE, et al. Characterization of photosensitivity in the Smith-Lemli-Opitz syndrome: a new congenital photosensitivity syndrome. Br J Dermatol 1999; 141:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/75\">",
"      Sanders CJ, Van Weelden H, Kazzaz GA, et al. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 2003; 149:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/76\">",
"      Lehmann P, H&ouml;lzle E, Kind P, et al. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 1990; 22:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/77\">",
"      Srivastava M, Rencic A, Diglio G, et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003; 139:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/78\">",
"      Lowe G, Henderson CL, Grau RH, et al. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol 2011; 164:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/79\">",
"      Callen JP. Drug-induced subacute cutaneous lupus erythematosus. Lupus 2010; 19:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?17/63/18426/abstract/80\">",
"      Lai-Cheong JE, Tanaka A, Hawche G, et al. Kindler syndrome: a focal adhesion genodermatosis. Br J Dermatol 2009; 160:233.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6622 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-221.179.173.170-9A4DD99832-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18426=[""].join("\n");
var outline_f17_63_18426=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H37\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      THE IDIOPATHIC PHOTODERMATOSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Polymorphous light eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Actinic prurigo",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hydroa vacciniforme",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Clinical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12594781\">",
"      Chronic actinic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Solar urticaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      PHOTOSENSITIVITY DUE TO EXOGENOUS AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Phototoxicity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Phytophotodermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Other manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Photoallergy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      PHOTOSENSITIVITY DUE TO ENDOGENOUS AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Porphyria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Smith-Lemli-Opitz syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      PHOTOEXACERBATED DERMATOSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Drug-induced subacute cutaneous lupus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Dermatomyositis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      RARE GENODERMATOSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/6622\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/6622|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/0/30735\" title=\"picture 1\">",
"      Actinic prurigo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/39/40562\" title=\"picture 2A\">",
"      Hydroa vacciniforme 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/14/23779\" title=\"picture 2B\">",
"      Hydroa vacciniforme 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/54/30562\" title=\"picture 3\">",
"      Chronic actinic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/13/34003\" title=\"picture 4\">",
"      Solar urticaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/0/28675\" title=\"picture 5A\">",
"      Phototoxic eruption 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/0/34819\" title=\"picture 5B\">",
"      Phototoxic eruption on face",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?35/46/36582\" title=\"picture 5C\">",
"      Phototoxic eruption new",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/61/27603\" title=\"picture 6A\">",
"      Phytophotodermatitis 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/24/34182\" title=\"picture 6B\">",
"      Phytophotodermatitis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/46/7907\" title=\"picture 7\">",
"      Photoallergic eruption 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/6622|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/1/15390\" title=\"table 1\">",
"      Photosensitive disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/39/14972\" title=\"table 2\">",
"      Phototoxic and photoallergic reactions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/63/2044\" title=\"table 3\">",
"      Phytophotodermatitis causes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/42/35493?source=related_link\">",
"      Bloom syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/8/27784?source=related_link\">",
"      Clinical use of St. John's wort",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/42/5801?source=related_link\">",
"      Congenital erythropoietic porphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28106?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical features of epidermolysis bullosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/29/15834?source=related_link\">",
"      Erythropoietic protoporphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/45/41687?source=related_link\">",
"      Hereditary coproporphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/37/602?source=related_link\">",
"      Hereditary neuropathies associated with generalized disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36378?source=related_link\">",
"      Mucocutaneous manifestations of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/32/27142?source=related_link\">",
"      Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/43/29368?source=related_link\">",
"      Pathogenesis and clinical manifestations of juvenile dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24666?source=related_link\">",
"      Physical urticarias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/62/20455?source=related_link\">",
"      Polymorphous light eruption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28458?source=related_link\">",
"      Porphyria cutanea tarda and hepatoerythropoietic porphyria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/19/28984?source=related_link\">",
"      Porphyrias: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/27/30136?source=related_link\">",
"      Sunburn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24586?source=related_link\">",
"      The genodermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/51/825?source=related_link\">",
"      Variegate porphyria",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f17_63_18427="Contact collision sports";
var content_f17_63_18427=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71147&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=10\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Contact or collision sports",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Basketball",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Boxing*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Diving",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Field hockey",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Football (tackle)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ice hockey&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lacrosse",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Martial arts",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rodeo",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rugby",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ski jumping",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Soccer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Team handball",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Water polo",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Wrestling",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Participation not recommended by the American Academy of Pediatrics (AAP).",
"     <br>",
"      &bull; To reduce injuries, the AAP recommends limiting the amount of body-checking permitted for hockey players &le;15 years.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: American Academy of Pediatrics. Medical conditions affecting sports participation (RE0046). Pediatrics 2001; 107:1205.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18427=[""].join("\n");
var outline_f17_63_18427=null;
var title_f17_63_18428="Indications for skin biopsy";
var content_f17_63_18428=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F67185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F67185&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for skin biopsy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Indication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical presentation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Possible diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Biopsy technique",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"11\">",
"        Diagnosis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"9\">",
"        Rashes or blisters involving dermis",
"       </td>",
"       <td>",
"        Drug reaction",
"       </td>",
"       <td colspan=\"1\" rowspan=\"9\">",
"        Punch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cutaneous lymphoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Deep tissue infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythema multiforme",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kaposi's sarcoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pemphigoid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psoriasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Processes involving the subcutis",
"       </td>",
"       <td>",
"        Erythema nodosum",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Excision",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Panniculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"9\">",
"        Diagnosis and",
"treatment",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Atypical moles and",
"pigmented lesions",
"       </td>",
"       <td>",
"        Dysplastic",
"nevi&nbsp;",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Excision or punch (for",
"small lesions)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malignant melanoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"7\">",
"        Superficial lesions",
"       </td>",
"       <td>",
"        Actinic keratoses",
"       </td>",
"       <td colspan=\"1\" rowspan=\"7\">",
"        Shave (into dermis for suspected malignancy) or excision",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Basal cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Seborrheic keratosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pyogenic granuloma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skin tags",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Squamous cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Warts",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     With permission from Alguire, PC, Mathes, BM, J Gen Intern Med 1998; 13:46.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18428=[""].join("\n");
var outline_f17_63_18428=null;
var title_f17_63_18429="ESC 2008 CM familial";
var content_f17_63_18429=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F64479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F64479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Familial types of cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        HCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        DCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        ARVC",
"       </td>",
"       <td class=\"subtitle1\">",
"        Arrhythmogenic CM",
"       </td>",
"       <td class=\"subtitle1\">",
"        RCM",
"       </td>",
"       <td class=\"subtitle1\">",
"        Unclassified",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        Sarcomeric protein mutations",
"        <ul>",
"         <li>",
"          &Beta; myosin heavy chain",
"         </li>",
"         <li>",
"          Cardiac myosin binding protein C",
"         </li>",
"         <li>",
"          Cardiac troponin I",
"         </li>",
"         <li>",
"          Troponin-T",
"         </li>",
"         <li>",
"          &alpha;-tropomyosin",
"         </li>",
"         <li>",
"          Essential myosin light chain",
"         </li>",
"         <li>",
"          Regulatory myosin light chain",
"         </li>",
"         <li>",
"          Cardiac actin",
"         </li>",
"         <li>",
"          &alpha;-myosin heavy chain",
"         </li>",
"         <li>",
"          Titin",
"         </li>",
"         <li>",
"          Troponin C",
"         </li>",
"         <li>",
"          Muscle LIM protein",
"         </li>",
"        </ul>",
"        <p>",
"         Glycogen storage disease (eg, Pompe; PRKAG2, Forbes', Danon)",
"        </p>",
"        <p>",
"         Lysosomal storage diseases (eg, Anderson-Fabry, Hurler's)",
"        </p>",
"        <p>",
"         Disorders of fatty acid metabolism",
"        </p>",
"        <p>",
"         Carnitine deficiency",
"        </p>",
"        <p>",
"         Phosphorylase B kinase deficiency",
"        </p>",
"        <p>",
"         Mitochondrial cytopathies",
"        </p>",
"        Syndromic HCM",
"        <ul>",
"         <li>",
"          Noonan's syndrome",
"         </li>",
"         <li>",
"          LEOPARD syndrome",
"         </li>",
"         <li>",
"          Friedreich's ataxia",
"         </li>",
"         <li>",
"          Beckwith-Wiedermann syndrome",
"         </li>",
"         <li>",
"          Swyer's syndrome",
"         </li>",
"        </ul>",
"        Other",
"        <ul>",
"         <li>",
"          Phospholamban promoter",
"         </li>",
"         <li>",
"          Familial amyloid",
"         </li>",
"        </ul>",
"       </td>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        <p>",
"         Sarcomeric protein mutations (see HCM)",
"        </p>",
"        Z-band",
"        <ul>",
"         <li>",
"          Muscle LIM protein",
"         </li>",
"         <li>",
"          TCAP",
"         </li>",
"        </ul>",
"        Cytoskeletal genes",
"        <ul>",
"         <li>",
"          Titin",
"         </li>",
"         <li>",
"          Dystrophin",
"         </li>",
"         <li>",
"          Desmin",
"         </li>",
"         <li>",
"          Metavinculin",
"         </li>",
"         <li>",
"          Sarcoglycan complex",
"         </li>",
"         <li>",
"          CRYAB",
"         </li>",
"         <li>",
"          Epicardin",
"         </li>",
"        </ul>",
"        Nuclear membrane",
"        <ul>",
"         <li>",
"          Lamin A/C",
"         </li>",
"         <li>",
"          Emerin",
"         </li>",
"        </ul>",
"        <p>",
"         Mildly dilated CM",
"        </p>",
"        <p>",
"         Intercalated disc protein mutations (see ARVC)",
"        </p>",
"        Mitochondrial cytopathy",
"       </td>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        Intercalated disc protein mutations",
"        <ul>",
"         <li>",
"          Plakoglobin",
"         </li>",
"         <li>",
"          Desmoplakin",
"         </li>",
"         <li>",
"          Plakophilin 2",
"         </li>",
"         <li>",
"          Desmoglein 2",
"         </li>",
"         <li>",
"          Desmocollin 2",
"         </li>",
"        </ul>",
"        Transforming growth factor-&beta;3 (TGF-&beta;3)",
"       </td>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        <p>",
"         Intercalated disc protein mutations (see ARVC)",
"        </p>",
"        <p>",
"         Lamin A/C",
"        </p>",
"        SCN5A",
"       </td>",
"       <td>",
"        <p>",
"         Familial, unknown gene",
"        </p>",
"        Sarcomeric protein mutations",
"        <ul>",
"         <li>",
"          Troponin I (RCM +/- HCM)",
"         </li>",
"         <li>",
"          Essential light chain of myosin",
"         </li>",
"        </ul>",
"        Familial amyloidosis",
"        <ul>",
"         <li>",
"          Transthyretin (RCM + neuropathy)",
"         </li>",
"         <li>",
"          Apolipoprotein (RCM + nephropathy)",
"         </li>",
"        </ul>",
"        <p>",
"         Desminopathy",
"        </p>",
"        <p>",
"         Pseuxanthoma elasticum",
"        </p>",
"        <p>",
"         Haemochromatosis",
"        </p>",
"        <p>",
"         Anderson-Fabry disease",
"        </p>",
"        Glycogen storage disease",
"       </td>",
"       <td>",
"        Left ventricular non-compaction",
"        <ul>",
"         <li>",
"          Barth syndrome",
"         </li>",
"         <li>",
"          Lamin A/C",
"         </li>",
"         <li>",
"          ZASP",
"         </li>",
"         <li>",
"          &alpha;-dystrobrevin",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ARVC: arrhythmogenic right ventricular cardiomyopathy; DCM: dilated cardiomyopathy; HCM: hypertrophic cardiomyopathy; RCM: restrictive cardiomyopathy.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Elliott P, Anderson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial disease. Eur Heart J 2008; 29:270. Copyright &copy; 2008 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18429=[""].join("\n");
var outline_f17_63_18429=null;
var title_f17_63_18430="Contents: Diet and weight";
var content_f17_63_18430=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?18/22/18798\">",
"       Patient Information",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Diet and weight",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Diet and weight",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Deficiencies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/15/6387\">",
"           Patient information: Vitamin B12 deficiency and folate (folic acid) deficiency (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/62/15331\">",
"           Patient information: Vitamin D deficiency (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/45/10962\">",
"           Patient information: Vitamin D deficiency (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diet",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40835\">",
"           Patient information: Controlling your blood pressure through lifestyle (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/62/28642\">",
"           Patient information: Diet and health (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/35/11827\">",
"           Patient information: Diet and health (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/51/35634\">",
"           Patient information: High-fiber diet (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Exercise",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40835\">",
"           Patient information: Controlling your blood pressure through lifestyle (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/42/7844\">",
"           Patient information: Exercise (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/39/20083\">",
"           Patient information: Exercise (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Obesity and overweight",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/53/3923\">",
"           Patient information: Health risks of obesity (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Special diets",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40835\">",
"           Patient information: Controlling your blood pressure through lifestyle (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/40/36483\">",
"           Patient information: Diabetes and diet (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/9/25746\">",
"           Patient information: Gluten-free diet (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/39/8817\">",
"           Patient information: High-fiber diet (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/51/35634\">",
"           Patient information: High-fiber diet (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/41/42640\">",
"           Patient information: Low potassium diet (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/61/39890\">",
"           Patient information: Low sodium diet (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/33/8722\">",
"           Patient information: Low-potassium diet (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/19/41266\">",
"           Patient information: Low-sodium diet (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/20/3397\">",
"           Patient information: Type 1 diabetes mellitus and diet (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/32/31239\">",
"           Patient information: Type 2 diabetes mellitus and diet (Beyond the Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Vitamins and supplements",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/62/27618\">",
"           Patient information: Probiotics (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/15/6387\">",
"           Patient information: Vitamin B12 deficiency and folate (folic acid) deficiency (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/57/13202\">",
"           Patient information: Vitamin D for babies and children (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/38/40546\">",
"           Patient information: Vitamin supplements (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Weight loss",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/55/3954\">",
"           Patient information: Care after weight loss surgery (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/37/9811\">",
"           Patient information: Weight loss surgery (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/31/14835\">",
"           Patient information: Weight loss surgery (The Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/5/33876\">",
"           Patient information: Weight loss treatments (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/52/31554\">",
"           Patient information: Weight loss treatments (The Basics)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-362B01F3B5-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f17_63_18430=[""].join("\n");
var outline_f17_63_18430=null;
var title_f17_63_18431="Aortogram of a bronchopulmonary sequestration";
var content_f17_63_18431=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81513&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81513&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aortogram of a left lower lobe bronchopulmonary sequestration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 278px; height: 366px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Aortogram demonstrating the systemic (aortic) origin of the arterial blood supply of a left lower lobe&nbsp;introlobar pulmonary&nbsp;sequestration (ILS). Note that the feeding vessels arise from the subdiaphragmatic aorta (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher Oermann, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f17_63_18431=[""].join("\n");
var outline_f17_63_18431=null;
